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GENERAL INTRODUCTION 
Acyl coenzyme A:retinol O—acyltransferase (ARAT; EC 
2.3.1.76) is a microsomal enzyme that catalyzes the 
esterification of retinol with fatty acids, using a fatty-
acyl—CoA thioester as donor of the acyl group (1). Inasmuch 
as vitamin A is stored in the liver as esters of retinol (2), 
ARAT may participate directly in the generation of an animal's 
reserves of this vitamin in vivo. Because the present work is 
a study of this transacylation and of certain biochemical 
properties of ARAT, and because the results are interpreted 
physiologically, both the biochemistry of vitamin A and the 
enzymology of ARAT are reviewed here. 
Biochemistry of Vitamin A 
Unable to synthesize vitamin A, animals must rely on their 
diet to provide it. The ultimate chemical source of vitamin A 
for animals is the group of fat—soluble plant pigments known 
as "carotenoids". Although several hundred carotenoids are 
known (3), only about 50 have the potential to serve as 
precursors of vitamin A in the animal (4). Of these vitamin— 
A—active carotenoids, 6-carotene is the most potent as well as 
the most abundant (5). 
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After being eaten by the animal, 3—carotene enters the 
lumen of the small intestine, where, because of its 
hydrophobicity, it is emulsified with other dietary lipids by 
bile salts. The micelles so formed passively diffuse across 
the microvillus membrane and into the mucosal cell (6). The 
g—carotene is then cleaved at the 15—15' double bond by a 
dioxygenase in the mucosal cell to yield two molecules of 
retinal (7,8). Evidence for a second mechanism whereby 3-
carotene is cleaved has been reviewed by Ganguly and Sastry 
(9). Cleavage in this mechanism is random rather than 
central, yielding only one molecule of retinal. Irrespective 
of mechanism, newly generated retinal is then reduced to 
retinol by a thiol— and pyridine—nucleotide—dependent aldehyde 
reductase (10). In the gut, retinol also arises directly from 
the hydrolysis of retinyl esters (11), the form of vitamin A 
in foods of animal origin, in fortified foods (e.g., milk and 
breakfast cereals), and in vitamin pills. 
A cellular retinol-binding protein, type "II", (CRBP 
(ID), then binds its insoluble ligand, retinol, carrying it 
to intracellular sites of esterification (12). Although 
retinol is eaterified in the small—intestinal mucosa (13,14), 
the role of ARAT in catalysis of the reaction in vivo is 
uncertain (14), especially with the recent discovery of an 
acyl-CoA-independent retinol acylase in the small intestine 
(15). The relative contribution of these enzymes to the total 
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rate of retinol esterification in vivo is unknown. Regardless 
of the enzyme, newly formed retinyl esters are subsequently 
packaged into the hydrophobic core of chylomicrons, along with 
other dietary lipids, including absorbed B—carotene. Secreted 
by the enterocytes into surrounding lymph, chylomicrons 
ultimately enter the blood through the thoracic duct (16). 
As the chylomicrons circulate, the core triacylglycerols 
are hydrolyzed by lipoprotein lipase on the surface of 
capillary endothelium (17), whereas the retinyl esters escape 
hydrolysis during this phase of chylomicron processing (18). 
Thereby enriched in vitamin A, the "chylomicron remnants" 
arising from this lipolysis are eventually removed from 
circulation by the liver (19) in a receptor—mediated 
endocytosis. After fusion of lysosomes with the vesicles 
created by this endocytosis, degradation of the vesicles' 
contents begins (20). There is evidence, however, that 
vitamin A in the endocytosed vesicles is transferred directly 
to the endoplasmic reticulum rather than being engulfed by 
lysosomes (21). 
Although it has been known for many years that retinyl 
esters in the chylomicron remnant are hydrolyzed after 
reaching the liver (22), it is not known whether hydrolysis 
occurs before fusion of the endocytosis vesicles with 
lysosomes, catalyzed presumably by a plasma-membrane—bound 
hydrolase, or after fusion, catalyzed by a lysosomal acid 
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hydrolase. After hydrolysis of its esters, hepatic retinol 
will follow one of three possible paths: 1) binding to plasma 
retinol-binding protein (RBP) for secretion into the blood, 2) 
oxidation or conjugation for excretion by the animal, and 3) 
ester ification and storage in the liver. 
The binding of retinol to apo-RBP and the subsequent 
secretion of holo-RBP are particularly rapid when hepatic 
reserves of vitamin A are low (23,24). Retinol is bound by 
apo-RBP in the endoplasmic reticulum, and the holo-RBP so 
formed is then secreted into the blood in Golgi—derived 
vesicles (25,26). In retinol deficiency, apo-RBP accumulates 
in the liver (27,28), but immediately binds retinol upon 
repletion, quickly entering the blood as hoio—RBP (28). 
Reactions whereby retinoids are oxidized or conjugated in 
cell—free systems or by cells in culture are numerous. 
Retinol can be oxidized reversibly to retinal by a pyridine-
nucleotide—dependent enzyme present in the small intestine 
(29), liver (30), and eye (31). Retinal, in turn, can be 
oxidized to retinoic acid by another pyridine—nucleotide— 
dependent enzyme that has been identified in several tissues, 
including the liver (32,33). Whereas the dehydrogenase for 
retinol and for ethanol may be the same enzyme in the liver 
(30), in kidney cells they are distinct (34). 
The interconversion of retinol and retinal is important 
physiologically in at least two respects: 1) retinol must be 
5  
oxidized to retinal in the eye because the-aldehyde is the 
prosthetic group of rhodopsin (35), and 2) retinal must be 
reduced to retinol in the small intestine after oxidative 
cleavage of carotenoids in order for these pigments ultimately 
to have provitamin A activity. 
On the contrary, the importance of the irreversible 
oxidation of retinal to retinoic acid is physiologically 
obscure. Although the acid is generally more active than 
other retinoids in cell—culture systems (36), whether or not 
retinoic acid is an obligatory metabolite of vitamin A is 
unknown. Among the many enzyme—catalyzed reactions that 
retinoic acid itself can undergo in vitro are glucuronidation 
(37), decarboxylation (38), epoxidation (39), and 
isomerization (40). 
Unfortunately, most retinoid metabolites occurring in 
urine, bile, and feces have not been characterized well. 
Water—soluble metabolites of retinol, presumably oxidation 
products, have been found in the urine (22). Retinyl B— 
glucuronide has been identified in bile (41), along with 
retinoic acid and its conjugates (42). However, a recent 
study unequivocally identified 4—hydroxyretinol among the 
polar metabolites of retinol in incubations with rat—liver 
microsomes (43). The formation of 4-hydroxyretinol was 
dependent upon Og, NADPH, and cytochrome P—450. Because no 
retinoic acid was detected among the reaction products, the 
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authors concluded that retinoic acid is not an obligatory-
intermediate in the pathway for retinol oxidation catalyzed by 
liver microsomes. Furthermore, V and K_ are such that this 
max m 
pathway may be physiologically significant. 
Mammalian microsomes also catalyze the transfer of mannose 
from GDP-mannose to retinyl phosphate (44,45). Retinol can be 
phosphorylated in vitro (46—49) in an ATP—dependent reaction 
(46), and, indeed, S—mannosylphosphorylretinol (retinyl 
phosphate mannose) has been isolated from whole liver (49) and 
from hepatic membrane preparations (50). Although only a 
small proportion of hepatic vitamin A is in the form of 
retinyl phosphate mannose at any given time (49), the theory 
that vitamin A functions in the mannosyl—transfer reactions of 
glycoprotein biosynthesis has been proposed (51). 
Another microsome—catalyzed reaction generates retinyl g— 
glucuronide (41), already mentioned as a metabolite in bile. 
In this non—oxidative conjugation, uridine diphosphoglucuronic 
acid donates the glucuronyl moiety to retinol to form the 
acetal product. Although the physiological role of this 
compound is still a mystery, its presence in human blood has 
been proven (52). 
The most thoroughly studied reaction of retinol, however, 
is also the one whose physiological role in the biochemistry 
of vitamin A is relatively well—understood. This reaction is 
esterification, catalyzed by ARAT, mentioned above. 
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Acyl Coenzyme A:Retinol 0—Acyltransferase 
ARAT is a microsomal enzyme that catalyzes the 
transacylation of retinol with fatty—acyl—CoA thioester 
derivatives (1). Present in a large variety of tissues and 
species, this enzyme has been identified in the liver of the 
rat (1), human (53), and chick (54), as well as in the mucosa 
of rat (55) and human (56) small intestine. ARAT activity has 
also been seen in lamb kidney (57), in a cell line derived 
from pig kidney (34), and in rat mamma (58), rat testis (59), 
and mouse epidermis (60). Uncharacterized retinol—acylating 
activity has been detected in rabbit lung (61) and in retinal 
pigment epithelium from the frog (62), human (63), and cow 
(64) . 
The in-vitro esterification of retinol by a cell—free 
system was first reported by Futterman and Andrews in 1964 
(2). Using cat liver, these workers found that most of the 
retinol—acylating activity was associated with the microsomes. 
Finding no requirement for supplements or cofactors (e.g., ATP 
and CoA), they concluded that the acylation reaction was 
energy-independent. In a 1982 report by Ross (1), however, 
the enzyme was characterized, but the data contradicted the 
conclusion of Futterman and Andrews (2). 
Ross (1) showed stimulation of the in-vitro esterification 
of retinol by addition to the reaction mixture of either a 
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fatty-acyl-CoA thioester derivative or a fatty acid with CoA 
3 1 4 
and ATP. Furthermore, when [ H]retinol and [ C]palmitoyl CoA 
3 14 
were incubated with microsomes, the ratio of H to C in the 
ester product was the same as in the substrates, evidence that 
the palmitoyl moiety was transferred directly to retinol, 
rather than first to an intermediate. Thus, Ross (1) 
classified the retinol—acylating activity as an 
acyltrans ferase. 
Ross (1) observed esterification even in the absence of 
exogenous fatty—acyl CoA, as long as retinol was included in 
the incubation with microsomes. Additional, albeit indirect, 
support for classifying the enzyme as an acyltransferase arose 
from elimination of this basal rate by treatment of the 
microsomes with hydroxylamine before incubation with retinol. 
Inasmuch as hydroxylamine reacts with fatty-acyl-CoA 
thioesters to form hydroxamates (65), fatty—acyl CoA must have 
been endogenous to the microsomes used by Ross. Because other 
reports for various tissues and species also have shown a 
requirement for activated fatty acids (52—60), the energy 
dependence of at least one microsomal retinol-acylating enzyme 
is now clear. 
Although the chemical mechanism of the transacylation 
catalyzed by ARAT has not been probed, sulfhydryl groups are 
known to be necessary for activity, whereas serine hydroxyl 
groups are probably unimportant. ARAT is inhibited by p— 
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chloromercuribenzoate (1,58), p-hydroxymercuribenzoate (59,60) 
5,5'-dithiobis-(2-nitrobenzoic acid) (55,56,59), and p-
chloromercuriphenylsulfonate (59), all of which are 
sulfhydryl-blocking agents, but not by phenylmethylsulfonyl 
fluoride (58,60), an inhibitor of serine—dependent enzymes. A 
requirement for metal ions is also unlikely inasmuch as EDTA 
fails to inhibit ARAT in vitro (58,59). Exogenous thiols, 
including dithiothreitoi (1,58-60), glutathione (1), and 
cysteine (1), as well as bovine serum albumin (1,55,56,58,59), 
accelerate the reaction in vitro when included in the 
incubation mixtures, although most reports are cursory on this 
point. 
Whereas the chemical events of the transacylation have not 
been elucidated, the physiological significance of ARAT has 
been investigated. ARAT is not the same microsomal enzyme 
that catalyzes the analogous transacylation of cholesterol, 
acyl CoA: cholesterol 0-acyltransferase (ACAT; EC 2.3.1.26). 
Their being the same enzyme has been precluded by at least 
five observations: 1) that retinol esterification was not 
inhibited in vitro, competitively or otherwise, by cholesterol 
(1), 2) that cholesterol esterification was inhibited in vitro 
by (3—[decyldimethylsilyl]—N—[2-(4—methylphenyl)—1-
phenylethyl]propanamide), whereas retinol esterification was 
not (66), 3) that, in the absence of added fatty—acyl CoA, 
cholesterol is esterified in vitro with mainly unsaturated 
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fatty acids (67), whereas those with which retinol is 
esterified are primarily saturated (2), 4) that treatment of 
cultured retinal pigment epithelial cells with butyrate 
stimulates the intracellular esterification of retinol but not 
that of cholesterol (63), and 5) that treatment of cultured 
rat—liver cells with 25—hydroxycholesterol or mevalonolactone 
accelerates the intracellular esterification of cholesterol 
but not that of retinol (68). The in-vitro distinction 
between ARAT and ACAT satisfies the expectation that vitamin A 
and cholesterol, two compounds with very different 
physiological roles, are routed into mutually exclusive 
biochemical pathways. 
In contrast to 3—carotene (69), vitamin A is potentially 
toxic (70). Moore speculates in his treatise on vitamin A 
that, inasmuch as the liver continues to function normally 
even when its concentration of vitamin A is abnormally high, 
esterification may be the liver's way of detoxifying retinol 
(71). Although not lowered by vitamin—A deficiency (72), ARAT 
activity is enhanced in liver microsomes from both rats (72) 
and chicks (73) on high vitamin-A intakes, but is not altered 
by the administration of retinoic acid (72). Consequently, if 
ARAT is present in species with exceptionally large hepatic 
vitamin-A reserves, e.g., the polar bear (74,75), its activity 
is expected to be higher in vitro than that of ARAT from most 
other species. 
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Vitamin-A toxicosis probably arises only when absorption 
of the vitamin by the intestine exceeds the liver's capacity 
for removing vitamin A from the blood, for esterifying it, and 
for sequestering it as it does, in vitamin—A—rich globules 
(76). Thus, ARAT's presence in the liver is a two—fold 
advantage in the sense that it 1) generates the chemical 
storage form of vitamin A, and 2) detoxifies retinol. Moore 
notes the irony that "...animals with high reserves of vitamin 
A might be in danger of poisoning themselves if they were able 
to eat their own livers" (71). 
While hepatic ARAT is inhibited in vitro by progesterone, 
deoxycholate, and taurocholate (1), retinol acylation by 
microsomes from various other tissues (whether or not the 
activity has been identified as ARAT) is inhibited by Triton 
X—100 (58), bile—salt detergents (55,56,58,59), and by 
retinoids, including 3,4-didehydroretinol (60,62), all-trans-
retinoic acid (60,77), 13-cis—retinol (60) and 4-
hydroxyretinol (60). Strictly speaking, 3,4—didehydroretinol, 
13—cis-retinol, and 4—hydroxyretinol probably do not truly 
inhibit the enzyme; they are more properly regarded as 
competing substrates, and, at least in the case of 3,4— 
didehydroretinol (62), inhibit by virtue of being esterified 
themselves. Whereas the in-vitro inhibition of ARAT by 
detergents suggests that this membrane-bound enzyme is 
sensitive to changes in its lipid environment, the inhibition 
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of small-intestinal ARAT by all—trans—retinoic acid (77) was 
interpreted as a threat to the synthesis and absorption of 
retinyl esters in cases where retinoic acid or similar 
retinoids are ingested in large quantities, e.g., therapy for 
acne. The inhibition of epidermal ARAT by retinol analogs 
(60) was interpreted non—physiologically by the authors as the 
absence of absolute enzyme specificity for the alcohol 
substrate. 
The predominant vitamin—A ester in the liver is retinyl 
palmitate, with smaller amounts of stearate, oleate, and 
linoleate (2,22,78). Futterman and Andrews (2) reported that, 
with no added fatty-acyl CoA, microsomes esterified retinol 
with a variety of fatty acids, namely, palmitate, stearate, 
palmitoleate, oleate, and linoleate. Although palmitoyl CoA 
has been the substrate of choice for in—vitro studies on ARAT 
in various tissues (1,53,55,56,58-60,72,77), the stearoyl 
(1,56,58,59), oleoyl (1,55,56,58,59), linoleoyl (60), lauroyl 
(1,58), and octanoyl (1,58) thioesters of CoA have been tested 
as substrates for the enzyme. 
For ARAT from rat (55) and human (56) small intestine, 
stearoyl and oleoyl CoA were less effective as substrates than 
palmitoyl CoA. The relationship was different, however, for 
lactating rat mamma: oleoyl > stearoyl > palmitoyl > lauroyl > 
octanoyl CoA (58). For rat testis, palmitoyl, stearoyl, and 
oleoyl CoA were equally effective substrates (59). In assays 
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for ARAT from mouse epidermis, linoleoyl CoA "could replace 
palmitoyl CoA as acyl donor", but their relative rates are not 
given in the report (60). Finally, hepatic ARAT showed still 
another order of substrate-effectiveness: palmitoyl > lauroyl 
> oleoyl > stearoyl > octanoyl CoA (1). 
No major research focusing on the enzymology of retinol 
esterification emerged between the report in which Futterman 
and Andrews demonstrated the in-vitro esterification of 
retinol by cat—liver microsomes (2) and the report by Ross in 
which the activity was characterized (1), an interim of 18 
years. Despite the ensuing flurry of research on ARAT, 
surprisingly little information has accrued on three 
particular fundamental biochemical and physiological aspects 
of the enzyme and the reaction it catalyzes. The research 
presented herein addresses these three issues. 
Firstly, if ARAT is indeed physiologically responsible for 
generating the chemical storage form of vitamin A, is the 
enzyme present in the liver of species whose reserves of 
vitamin A are naturally very large? If so, how do its 
activity and characteristics compare with those for other 
species? Furthermore, is ARAT present in tissues that do not 
accumulate retinyl esters, and, if so, can its activity be 
enhanced in these tissues by administration of vitamin A to 
the animal? 
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Secondly, although ARAT from other tissues is inhibited in 
vitro by various retinoids (60,62,77), both natural and 
synthetic, the specificity of the inhibition (i.e., whether or 
not these compounds affect other microsomal enzymes) has not 
been studied. Furthermore, is hepatic ARAT subject to 
inhibition by retinoids, and, if so, how inhibitory are those 
used therapeutically in the treatment of skin disorders or 
cancer? 
Thirdly, the predominance of retinyl palmitate in the 
liver over esters of retinol with other fatty acids (2,22,78) 
implies a specificity in ARAT for palmitoyl CoA. Although 
various fatty—acyl—CoA thioester derivatives have been 
compared as substrates for the in—vitro reaction, they have 
been incubated with microsomes singly, rather than together as 
competing substrates. Furthermore, the potential complication 
of microsomal acyl CoA hydrolases and BSA, which binds oleoyl 
CoA in vitro (79), have been ignored. Reports also have 
overlooked polyunsaturated and odd—chain fatty—acyl—CoA 
thioesters as substrates for ARAT. With these considerations, 
then, what is the specificity of ARAT in vitro, and does it 
account for the fatty-acid composition of retinyl esters in 
vivo? 
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PART I. 
ACYL COENZYME A:RETINOL 0-ACYLTRANSFERASE 
IN POLAR-BEAR LIVER AND RAT MAMMARY TUMOR AND ENHANCEMENT OF 
ITS ACTIVITY BY HIGH DOSES OF VITAMIN A 
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INTRODUCTION 
Whether the animals are dosed or vitamin A is added to the 
diet, large increases in vitamin—A intake are accompanied by 
an increase in the in—vitro activity of acyl CpA;retinol 0— 
acyltransferase (ARAT) in rat (72) and chick (73) liver, as 
well as in rat small intestine (72). This observation 
strengthens the hypothesis that ARAT is physiologically 
responsible, at least in part, for generating the chemical 
storage form of vitamin A. Justification for assigning 
physiological importance to ARAT also would be found in two 
other observations: 1) the presence of ARAT, and with an 
unusually high activity, in the liver of species whose 
reserves of vitamin A are naturally very large, and 2) the 
absence of ARAT, or its presence at an unusually low activity, 
in a tissue that does not store esters of retinol, and the 
enhancement of ARAT activity in such a tissue by 
administration of vitamin A to the animal. 
Among the animals known to have exceptionally large 
hepatic vitamin—A stores are the polar bear (74,75), certain 
seals (74,80), and other marine mammals, like the bowhead 
whale (75). Vitamin A has been quantified in several 
specimens of polar—bear liver, ranging in concentration from 
3900 wg/g tissue to 10,380 ug/g (74,75,81,82; concentrations 
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expressed as "lU/g" have been converted to "yg retinol/g" by 
the equation "1 lU = 0.3 us retinol"). 
The concentration of vitamin A in most animal livers is 
normally much smaller than in that of the polar bear. For the 
vitamin—A—normal rat, for example, values of 43 us/s liver 
(76) and 172 us/s (72) have been reported. Typical values for 
man are 173 us/S liver (83), 126 vs/s (84), and 211 us/s (85). 
Also lower than that of the polar bear, the hepatic 
concentrations of vitamin A have been measured for many other 
species as well. One study involved the livers of calf, 
sheep, rabbit, rat, frog, rainbow trout, and the domestic cat 
(2), while other studies have fotused on larger cats (86) and 
on chicks (73). 
From the accidental death of a polar bear at a nearby zoo 
arose the rare opportunity to ascertain not only whether 
polar—bear liver contains an unusually active ARAT, but also 
1) whether some properties of the enzyme are similar to those 
for ARAT from other species, 2) whether a polar bear raised in 
captivity also has very large hepatic reserves of vitamin A, 
and 3) whether the fatty—acid composition of retinyl esters in 
polar—bear liver is similar to that found in other species. 
At the opposite extreme, examples of tissues that do not 
store vitamin A are rat hepatoma (87) and rat mammary tumor 
(88; 0. Amedee—Manesme and H. C. Furr, Dept. of Biochemistry 
and Biophysics, Iowa State University, Ames, Iowa, personal 
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communication). ARAT in microsomes from another rat hepatoma 
cell—line (Fu5AH) catalyzed retinol esterification in vitro at 
a rate an order of magnitude lower than that for normal rat 
liver (66). Because it has not, however, been identified in a 
rat mammary tumor, ARAT in this tissue was assayed, and the 
response of its activity to administration of vitamin A to the 
animals was determined. For comparison, ARAT activity in the 
liver also was measured before and after dosing. 
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EXPERIMENTAL PROCEDURE 
Materials 
Retinal, retinyl acetate, retinyl palmitate, palmitoyl 
CoA, DL-dithiothreitol, bovine serum albumin (BSA; essentially 
globulin— and fatty—acid—free), were purchased from Sigma 
Chemical Co. (St. Louis, MO). n-Decane and 5-nonanone were 
supplied by Aldrich Chemical Co. (Milwaukee, WI). All other 
chemicals and solvents were of the highest quality 
commercially available. Under gold fluorescent laboratory 
lights (Sylvania F40G0) all-trans—retinol was prepared by 
reduction of all—trans—retinal in methanol with excess sodium 
borohydride, and then purified by high—pressure liquid 
chromatography (HPLC) on a Whatman Partisil M9 10/50 straight-
phase column (9.4 mm x 50 cm), with an eluting solvent of 
hexane/ethyl acetate (90:10, v/v), flowing at 7 mL/min. For 
the final stock solution, retinol was dissolved in 
dimethylsulfoxide (DMSO) and its concentration was determined 
_ i  _ i  
by absorbance in ethanol at 325 nm, with e = 52,480 W cm 
Palmitoyl CoA was dissolved in 150 mW potassium phosphate 
buffer, pH 7.4, and its concentration was determined by 
- 1  _ i  
absorbance at 259.5 nm (at pH 7.0), with e = 15,400 M cm 
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Animals 
Having been raised from a cub at Brookfield Zoo in 
Brookfield, IL, a male polar bear (Ursus maritimus) suffered a 
broken neck as the result of a fall. Killed shortly 
thereafter by lethal injection, at about 10 a.m., the bear was 
transported to the University of Illinois at Urbana—Champaign 
where, at about 3 p.m., the liver was removed and frozen. At 
death the bear was 14 years old and weighed about 850 pounds. 
While in captivity at Brookfield Zoo, the bear was 
maintained on Zu/Preem Omnivore Diet and Nebraska Brand canine 
diet (Animal Spectrum, Lincoln, NE) and Purina Field and Farm 
dry dog food (Ralston—Purina, Richmond, IN), raw unpeeled 
apples, white enriched bread, and smelt from Lake Superior. 
The bear's estimated daily consumption of about 13 kg of food 
includes 77,700 lU (23,300 ug) of vitamin A, 58% being 
supplied by the canine diet, 30% by the smelt, and 12% by the 
omnivore diet. Vitamin A was therefore consumed at 1770 pg/kg 
diet. Carotene was not detectable in the diet. Table 1 lists 
the estimated average quantities of diet components consumed 
daily by the bear. 
Fischer NHsd/344 female rats (Harlan Sprague-Dawley, 
Indianapolis, IN) were maintained on the AIN semi-purified 
diet (89; ICN Nutritional Biochemicals, Cleveland, OH), with 
free access to tap water. Ten animals received a daily oral 
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Table 1. Estimated average quantities of diet and components 
thereof consumed daily by the bear 
Component Quantity 
Total food 
Metabolizable 
Crude protein 
Crude fiber 
Fat 
Vitamin A 
Vitamin D 
Vitamin E 
energy 
13.155 kg 
8090 kcal 
1788 g 
152 g 
621 g 
77,669 lU 
11,461 lU 
72 mg 
^Information provided by Dr. Bruce Watkins of Brookfield 
Zoo, Brookfield, IL. 
dose of 2 mg retinyl acetate in corn oil, while ten others 
received the vehicle only. On day 8 of dosing, tumor cells 
were transplanted into the napes of five animals from each 
group according to the following procedure. One gram of tumor 
was minced in 10 mL Liebovitz' L—15 medium (GIBCO, Grand 
Island, NY), containing gentamycin sulfate, streptomycin 
sulfate, and penici11in-G; 0.1 mL of the resulting suspension 
was injected into the loose skin of the nape. The dosed group 
was sacrificed on day 18 and the control group on day 19. 
Animals were anesthetized with diethyl ether and their livers 
and tumors were removed. 
22 
Tumor 
Transplantable rat mammary—tumor cells were acquired from 
the late Dr. John Balinsky, Dept. of Zoology, Iowa State 
University. This tumor line, induced by dimethylbenz(a)— 
anthracene, was kindly provided by Dr. Olga Greengard of Mt. 
Sinai Hospital, New York, NY. The tumor was maintained in 
Fischer NHsd/344 female rats, being transferred biweekly. 
Preparation of Microsomes 
With a Polytron apparatus, frozen polar-bear liver, which 
had been stored at -20°C for about four months, was 
homogenized in 250 mM sucrose, buffered with 10 mH potassium 
phosphate, pH 7.4. The filtered homogenate was centrifuged at 
13,000 X g for 20 min in a Beckman JA—20 rotor at 4°C. The 
G 
supernatant solution was then centrifuged at 8 x 10 g*min in 
a Beckman 80Ti rotor at 4°C. Microsomes were washed once and 
suspended in 150 mM potassium phosphate buffer, pH 7.4, quick-
frozen in liquid nitrogen, and stored at —70°C. Microsomal 
protein was measured by the Bradford dye—binding method (90). 
Tumor samples were dissected free of necrotic tissue. 
With a motor—driven Teflon pestle, livers and tumors were 
homogenized in 250 mM sucrose, buffered with 10 mM potassium 
phosphate, pH 7.4. Microsomes were then prepared by the same 
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procedure as that used for bear liver. Microsomal protein was 
measured by absorbance at 280 nm, with BSA serving as 
standard. 
Measurement of Vitamin A 
Procedures for the extraction and spectrophotometric 
quantification of vitamin A were those previously described 
(91): about 1 g of frozen liver was mashed with sodium sulfate 
and its vitamin A was extracted with dichloromethane. The 
corrected absorbance of the extract at 325 nm was used in 
calculating the concentration of vitamin A in the liver. By 
the method of Furr et al. (92) retinyl esters and retinol were 
separated and quantified also by HPLC on a Waters Resolve 5—wm 
reversed—phase column, with a Waters 6000A pump used in 
conjunction with a Rheodyne injector, an LDC Spectromonitor 
III detector, which monitored absorbance at 325 nm, and a 
Shimadzu C-R2AX integrator. The eluting solvent, flowing at 
1.5 mL/min, was acetonitrile/dichloromethane (80:20, v/v) . 
Assay for Acyl CoA:Retinol O—Acylfcransferase 
The assay for ARAT was based on Ross' procedure (1). 
Microsomes were incubated with retinol, palmitoyl CoA, BSA, 
and dithiothreitol in 150 mM potassium phosphate buffer, pH 
24 
7.4, at a final volume of 0.5 mL. The reaction mixture 
without retinol was warmed in a shaking water bath at 37°C for 
60 sec, at which time retinol was introduced in < 5 jjL DMSO. 
Incubation lasted 15 min and 30 min for polar—bear and rat 
microsomes, repectively. Reaction was stopped by the addition 
of cold absolute ethanol at 2 mL per mL incubation solution, 
and the mixtures were then extracted with 2x1 mL hexane. 
The extracts were combined and the solvent was removed under 
argon. For subsequent analysis by HPLC the residue was 
dissolved in 75 yL n—decane/5-nonanone (2:1, v/v). Retinyl 
ester in the incubation extract was quantified by means of a 
standard curve relating peak area to the amount of ester 
injected. The amount of ester formed was the difference 
between that measured after incubation with active microsomes 
and that found after incubation with heat—inactivated 
microsomes. The HPLC system comprised a Waters 6000A pump in 
conjunction with a Waters WISP 710B autoinjector, a Shimadzu 
C—R3A Chromatopac integrator, and an ISCO V absorbance 
detector, monitoring at 325 nm. When analysis did not require 
the separation of retinyl esters, a Whatman Partisil CDS—2 
reversed—phase column was used with methanol/tetrahydrofuran 
(90:10 or 80:20, v/v), flowing at 1.5 mL/min. Retinyl esters 
were separated on a Waters Resolve 5—wm reversed—phase column, 
with acetonitrile/dichloromethane (80:20, v/v) as the eluting 
solvent, also at a flow rate of 1.5 mL/min (92). 
* 
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RESULTS AND DISCUSSION 
As determined by HPLC, retinyl esters were present in this 
polar—bear liver at a concentration of 7880 yg retinol/g wet 
tissue, whereas free retinol was present at 170 yg/g. The 
total concentration of vitamin A, then, was 8050 us/g, of 
which 98% was the ester form. By spectrophotometry the total 
vitamin—A concentration was somewhat lower (7400 vs/g)• Both 
values, however, fall in the range of those previously 
published for the polar bear. Despite his having been raised 
in captivity, the bear in this investigation had hepatic 
vitamin—A reserves on a scale with those of his wild cousins. 
He clearly was fed generous amounts of vitamin A, though how 
his intake compares with that of wild bears cannot be 
assessed. 
As shown in Table 2, retinyl palmitate was the predominant 
ester (37.3%), followed by retinyl oleate (20.9%), stearate 
(12.8%), and linoleate (7.7%). The pentadecanoate and 
heptadecanoate esters together accounted for 4.4% of the 
total. No other retinyl esters of odd—chain fatty acids were 
identified. Because all peak areas were proportionately 
smaller when absorbance was monitored at 280 or 450 nm, all 
peaks eluting after retinol were regarded as retinyl esters; 
no non—retinoid peaks were detected. 
The predominance of retinyl palmitate in this sample of 
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Table 2. Retinyl ester composition of polar-bear liver^ 
Retinyl ester 
Ug retino^/ 
g liver 
Percent of total 
ester concentration 
Laurate 163 2.1 
Myristate 155 2.0 
Pentadecanoate 136 1.7 
Palmitate 2936 37.3 
Heptadecanoate 208 2.6 
Stearate 1008 12.8 
Oleate 1647 20.9 
Linoleate 610 7.7 
Unidentified (8 peaks) 1015^ 12.9 
weighed portion of frozen polar—bear liver was mashed 
with sodium sulfate and its retinol and retinyl esters were 
extracted into dichloromethane. The extract was analyzed by 
reversed—phase HPLC, the esters being separated on a Waters 
Resolve 5—ym Cjg column. Eluting solvent was acetonitrile/ 
dichloromethane (80:20, v/v), flowing at 1.5 mL/min. The 
detector monitored absorbance at 325 nm. 
^Ester concentration is expressed in terms of the retinol 
moiety. 
^Largest peak represented 186 ug/g liver. 
polar—bear liver is consistent with the report of Futterman 
and Andrews (2), who found that ester to be predominant in the 
livers of all eight species they examined. In seven of the 
species, retinyl stearate and oleate followed palmitate in 
concentration, also seen in this bear liver. Retinyl 
linoleate, in contrast, was the fourth most concentrated ester 
in the bear liver while ranking fourth only in the frog liver 
in Futterman and Andrews' study; it was fifth to ninth in all 
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other species. 
Dietary intake is an attractive explanation for the 
relatively larger concentration of retinyl linoleate in bear 
liver. Furr et al. (93) reported that the fatty—acid 
composition of retinyl esters in the liver reflects changes in 
dietary fatty acids. Among their observations was an increase 
in the proportion of retinyl linoleate in rats fed large 
amounts of trilinolein. Although Tomassi and Olson (94) saw 
no effect of changes in dietary fatty acids on retinyl esters, 
their experiments were shorter-term than those of Furr et ai. 
(93). This question is discussed in Part III, pp. 91—92). 
The rate of retinol esterification was not higher when 
microsomes were incubated with retinol and palmitic acid 
unless CoA and ATP were present also, evidence for classifying 
the enzyme activity as an acyltransferase. ARAT activity 
increased with retinol concentration (Fig. lA), reaching a 
maximum at 80 wM of 821 pmol retinyl palmitate formed/min/mg 
microsomal protein. Because retinol was endogenous to the 
microsomes, retinyl ester was formed in the absence of 
exogenous retinol at a rate of 275 pmol/min/mg microsomal 
protein, or 33% of the maximum. The activity also rose with 
the concentration of palmitoyl CoA (Fig. IB), reaching a 
plateau at 50—65 yW. As in the case with retinol, ester was 
formed in the absence of exogenous fatty—acyl CoA, at a rate 
of 250 pmol/min/mg microsomal protein. 
Figure 1. Formation rate for retinyl palmitate as a function 
of retinol (A) and palmitoyl CoA (B) concentration. 
The reaction mixture comprised 15 uM BSA, 5 mM 
dithiothreitoi, and polar—bear—liver microsomes at 
300 vig protein/mL in 150 mW potassium phosphate 
buffer, pH 7.4. In A, palmitoyl CoA was present 
at 50 viM and in B, retinol was present at 80 uM. 
Incubation lasted 15 min. Each datum is the mean 
for duplicate trials, each vertical bar enclosing 
the range 
o-
CN 
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Whereas the largest increase in ARAT activity for polar-
bear liver by BSA was only 46% (Fig. 2A), an increase of 89% 
was seen for rat—liver ARAT, but only when exogenous acyl CoA 
was present in the reaction mixture (Table 3). Increases much 
more dramatic than that for polar—bear ARAT also have been 
reported for ARAT from the small intestine of rats (55) and 
humans (56), although the dependence of ARAT from human liver 
(53) on BSA was not reported. Considering the analogous BSA— 
dependent transacylation of cholesterol, Lichtenstein and 
Brecher (79) proposed that BSA, by binding fatty—acyl CoA, may 
prevent the latter's detergent—like action on the microsomes 
or increase the substrate's accessibility to the enzyme. In 
accord with this hypothesis, the data in Table 3 show that BSA 
had no effect on reaction rate when the only acyl—CoA 
substrate available to ARAT was endogenous. As the 
concentration of palmitoyl CoA in incubations with polar-bear 
microsomes rose from 50 to 80 jjM, the ratio of exogenous acyl 
CoA to BSA increased from 3.3:1 to 5.3:1, well above the ratio 
of 1:1 at which BSA binds oleoyl CoA (79). Polar-bear ARAT 
seems to be less sensitive to the detergency of palmitoyl CoA, 
the ratio of acyl CoA to BSA being about 3.3:1 before the 
reaction rate stopped responding to further increases in the 
concentration of palmitoyl CoA (Fig. 2A). 
ARAT was not appreciably affected by dithiothreitoi (Fig 
28), the reaction rate in its absence being 84% of the 
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Table 3. Stimulation of the activity of rat-liver ARAT by the 
addition of BSA or dithiothreitol (DTT) to the 
reaction mixture 
Additions to Pmol retinol esterified/ 
reaction mixture min/mg microsomal protein^ 
Experiment 1: 
none 208 
BSA (20 uM) 183 
BSA (60 yJI) 190 
palmitoyl CoA (60 uW) 187 
palmitoyl CoA (60 u«>, BSA (20 yM) 303 
palmitoyl CoA (60 uW), BSA (60 yW) 352 
Experiment 2 : 
none ND^ 
palmitoyl CoA (60 uW) ND 
palmitoyl CoA (60 uM), DTT (2 mrt) 181 
palmitoyl CoA (60 uW), DTT (6 mPI) 329 
^Values are means for duplicate trials, agreeing within 
5%. . 
^Basic reaction mixture comprised rat—liver microsomes 
(300 wg protein/mL) and 52 wW retinol in 150 mW potassium 
phosphate buffer, pH 7.4, at a final volume of 0.25 mL. This 
mixture also included either 5 mW dithiothreitol (Experiment 
1) or 20 yW BSA (Experiment 2). 
^"ND" = "not detectable". 
maximum. For rat-liver microsomes, however, dithiothreitol 
was a requirement for reaction (Table 3). Ross (1) reported 
that rat—liver ARAT was only 46% as active when dithiothreitol 
and BSA were absent from the reaction mixture as it was when 
they were present at 5 mil and 20 wW, respectively. Either the 
polar—bear enzyme is not dependent upon sulfhydryl groups or 
Figure 2. Formation rate for retinyl palmitate as a function 
of BSA (A) and dithiothreitol (B) concentration. 
The reaction mixture comprised 80 uM retinol, 50 uW 
palmitoyl CoA, and polar-bear—liver microsomes at 
300 us protein/mL in potassium phosphate buffer, pH 
7.4. In A, dithiothreitol was present at 5 mM and 
in B, BSA was present at 15 uM. Incubation lasted 
15 min. Each datum is the mean for duplicate 
trials, each vertical bar enclosing the range 
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the groups themselves are not prone to oxidation under the 
conditions of this experiment. 
Although Ross (1,66) reported some reaction rates for ARAT 
from rat liver on a par with the maximum reported here for the 
bear enzyme, a comparison of the plots of reaction rate as a 
function of retinol concentration reveals bear—liver ARAT to 
be the more active. The highest rate of esterification seen 
for rat—liver ARAT was about 400 pmol/min/mg microsomal 
protein, 49% of the maximal rate for its counterpart in the 
bear. ARAT activity for vitamin—A—normal rats is usually well 
below the rate of 821 cited for the bear (1,72,95; Table 1; 
Part II, p. 54). The highest reaction rate seen for ARAT from 
human liver was about 370 pmol/min/mg microsomal protein (53), 
or only 45% of the maximum for bear—liver ARAT. 
In response to an excess of vitamin A, the liver expands 
its stores of the vitamin by accelerating retinol 
esterification. Such an increase in the tissue concentration 
of retinyl esters has been noted in lamb liver and kidney 
(57,96), chick liver (73), and rat liver (72). Inasmuch as 
ARAT activity is enhanced by larger—than—normal consumption of 
vitamin A (72,73), ARAT in polar-bear liver may be very active 
as the result of genetic programming or it may simply be in a 
state of perpetual enhancement because of the bear's constant 
large dietary supply of retinol. Whatever the reason for it, 
the unusually high activity of hepatic ARAT in the polar bear, 
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Table 4. ARAT activity in rat liver and mammary tumor before 
and after dosing with retinyl acetate 
Tumor—bearing 
Tumor—free 
Tumor Liver Liver 
Control 12 ± 5 68 ± 17 170 ± 31 
Dosed 34 ± 23 280 ±110 260 ± 74 
Dosed/Control 2.8 4.1 1.5 
Value of p < 0.07 < 0.025 < 0.05 
All incubation mixtures comprised 20 mW BSA, 5 mW 
di thiothrei toi, 100 jjM retinol, 100 uN palmitoyl CoA, and 
microsomes at 400 yg protein/mL, in 150 mM potassium phosphate 
buffer, pH 7.4, at a final volume of 0.5 mL. Mean values ± 
standard deviations are reported for five animals, expressed 
as "pmol retinyl palmitate formed/min/mg microsomal protein". 
Each incubation, 30 min in length, was conducted in duplicate. 
Values of p were calculated by means of Student's t test. 
a species whose reserves of vitamin A are naturally very 
large, bolsters the hypothesis that ARAT plays a physiological 
role in the storage of vitamin A. 
Microsomes from rat mammary tumor also contain an enzyme 
activity that responds in vitro to the addition of retinol and 
palmitoyl CoA (Table 4). Thus, while vitamin A is 
undetectable in it (88; 0. Amedee-Manesme and H. C. Furr, 
Dept. of Biochemistry and Biophysics, Iowa State University, 
Ames, Iowa, personal communication), mammary tumor tissue has 
the chemical machinery for synthesizing retinyl esters. 
However, the specific activity of ARAT in tumor microsomes was 
only 1% of that in microsomes from normal rat liver, and only 
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13% even after administration of vitamin A to the rats. ARAT 
activity was enhanced in this investigation not only in 
mammary tumor, but also in rat liver (Table A), in accord with 
other reports (72,73). 
As expected physiologically, then, ARAT activity in rat 
mammary tumor, a tissue that does not store vitamin A, is very 
low relative to that in liver, a tissue with substantial 
reserves of the vitamin. This observation and the fact that 
the activity of tumor ARAT was enhanced by administration of 
vitamin A to the animals (although the statistical 
significance is marginal) are additional evidence for ARAT's 
physiological role in vitamin—A storage. Moreover, the 
enhancement of ARAT activity by dosing with vitamin A may be a 
response to the toxicological threat posed by excess retinol 
in the liver. 
Inasmuch as vitamin A is undetectable in rat mammary 
tumor, the presence of ARAT in this tissue has other 
implications. Given that ARAT activity, albeit very low, 
should be sufficient to form detectable amounts of retinyl 
ester in vivo, the tumor tissue may L) catabolize vitamin A 
quickly, 2) be supplied with less vitamin A than normal 
tissues, or 3) not effectively absorb vitamin A from the 
blood. Any of these possibilities could lower the tumor's 
concentration of vitamin A to very low values. 
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ARAT activity in the liver of tumor-bearing rats was 60% 
lower than that in normal liver (Table 4). Administration of 
vitamin A not only enhanced the activity in liver but also 
equalized liver ARAT activities in tumor—bearing and tumor-
free rats. Whereas the depression of ARAT activity in tumor-
bearing rats must have resulted from some influence exerted by 
the tumor on the liver, the nature of' the inhibition is not 
clear. In contrast, the activities of specific isozymes of 
hexokinase and pyruvate kinase in liver are higher in animals 
bearing this tumor (97). Whether the mechanism of in-vivo 
ARAT enhancement by vitamin A involves enzyme induction, 
stimulation, or removal of inhibition remains to be proven. 
Although the data in this section do not preclude the 
possibility that more than one enzyme is involved, they 
strongly support the hypothesis that ARAT has a physiological 
role in the esterification of retinol in the liver. An acyl— 
CoA—independent retinol—acylating activity has been identified 
recently in microsomes from rat small intestine (15) and the 
properties of the enzyme differ from those published for 
small—intestinal ARAT (55,56). 
The acyl-CoA—independent activity, whose substrates are 
retinol bound to CRBP(II) and an unknown endogenous acyl 
donor, produces retinyl esters whose fatty—acid composition 
more nearly matches that of in-vivo retinyl esters than do 
esters formed by the ARAT—catalyzed reaction. Furthermore, 
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the of the acyl—CoA-independent activity is 0.2 jjW (15), at 
least an order of magnitude lower than K for ARAT from rat 
m 
(55) or human (56) small intestine. Therefore, ARAT may 
operate in vivo whenever the concentration of retinol exceeds 
what the other acylating system can handle, although whether 
or not such a pair of enzymes exists in the liver is unknown. 
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PART II. 
DISRUPTION OF MICROSOMES BY 13-cis-RETINOIC ACID 
AND ITS INHIBITION OF RETINOL ESTERIFICATION 
AND BENZO(a)PYRENE HYDROXYLATION 
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INTRODUCTION 
Conclusions from studies on the inhibition of ARAT in 
vitro by retinoids have been drawn without data on the 
influence of these compounds on other microsomal enzyme 
systems (60,62,77). Furthermore, not only has inhibition of 
hepatic ARAT by retinoids not been reported, but the most 
commonly used therapeutic retinoid, 13—cis—retinoic acid, has 
escaped attention altogether as a possible inhibitor of 
retinol esterification in vitro. 
13—cis-Retinoic acid (13-c-RA), known also as 
"isotretinoin" (Accutane ), is a vitamin-A analog used as a 
drug in the treatment of recalcitrant acne (98). Among the 
side—effects of therapy with this drug are hyperlipidemia and 
a fall in the proportion of cholesterol in high—density 
lipoproteins (99—101). In rats, 13—c-RA not only raises the 
level of triacylglycerols in serum (102,103) but also changes 
the composition of both hepatic phospholipids (104,105) and 
microsomal fatty acids (105). Dosing rats with 7 wmol of 
retinyl acetate for 17 days also changed the fatty—acid 
composition both of total liver lipids and of retinyl esters 
(H. C. Furr and J. A. Olson, Dept. of Biochemistry and 
Biophysics, Iowa State University, Ames, Iowa, personal 
communication). Moreover, 13-C-RA both increases the 
concentration of lipid peroxides and decreases the level of a— 
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tocopherol in the plasma and liver of rats (106). 
The site of the adverse effects of 13—c—RA may well be 
cellular membranes. For example, 13—c—RA disrupts 
mitochondrial membranes in vitro with a high degree of 
molecular specificity (107). Furthermore, all—trans—retinoic 
acid (all-t-RA) inhibits microsome-catalyzed lipid 
peroxidation (108), whereas 13—c-RA raises the activity of the 
microsomal A6—desaturase while lowering that of the A9— 
desaturase (105). 
In testing for further interactions between 13-c—RA and 
membranes, three microsome-catalyzed reactions were selected; 
mannose-6-phosphate (M6P) hydrolysis, retinol esterification, 
and benzo(a)pyrene hydroxylation. Changes in the activity of 
mannose—6—phosphatase (M6Pase) are used as an index of the 
integrity of microsomal membranes (109—111). Because the 
active site of M6Pase is lumenal, an increase in the rate of 
M6P hydrolysis is interpreted as a greater membrane 
permeability to the substrate, reflecting membrane disruption. 
Vitamin—A metabolism is altered by 13—c—RA, in that the drug 
causes a fall in the concentration of serum retinol 
(102,103,106), and some patients on therapy with it have 
developed night blindness (112), a classic sign of vitamin A 
deficiency (113). Finally, the genetic modification of murine 
bone—marrow cells by benzo(a)pyrene, which is activated by 
hydroxylation, is prevented by vitamin A (114). 
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For the sake of comparison, W—(4—hydrojcyphenyl ) — 
retinamide, retinyl S-D-glucuronide, 15-methylretinol (each 
all—trans in configuration), and all—t—RA were also tested as 
in-vitro inhibitors of ARAT. 
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EXPERIMENTAL PROCEDURE 
Materials 
Retinoic acid, both all—trans and 13—cis, were purchased 
from Eastman Kodak Co. (Rochester, NY). Retinal, retinyl 
palmitate, palmitoyl CoA, DL-dithiothreitoi, BSA (essentially 
globulin— and fatty—acid-free), benzo(a)pyrene, palmitic acid, 
taurocholic acid, and NADPH were supplied by Sigma Chemical 
Co. (St. Louis, MO). 3—Hydroxybenzo(a)pyrene was obtained 
from Midwest Research Institute (Kansas City, MO) and 3—[(3-
cholamidopropyl)-dimethyl-ammonio]—l—propane sulfonic acid 
(CHAPS) from Calbiochem-Behring (La Jolla, CA). Barium 
mannose—6—phosphate (M6P) was purchased from Boehringer 
Mannheim (Indianapolis, IN). W—(4—hydroxyphenyl)retinamide 
were synthesized by Dr. Arun Barua of Iowa State University 
(115), as was retinyl 3-glucuronide (116). 15—Methylretinol 
was prepared by the method of Tosukhowong and Olson (117), in 
which methylation was accomplished with methyl lithium. All 
other chemicals and solvents were of the highest quality 
commercially available. all—trans-Retinol was prepared and 
its concentration determined as before (Part I, p. 19). all-
t— and 13—c—RA were dissolved in DMSO and the concentration of 
each was determined by absorbance at its X (A and E for 
max max 
all-t- and 13—c—RA, respectively; 350 nm, 45,200 W~^cm~^, and 
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354 nm, 39,800 W~^cin~^). The stock solution of palmitoyl CoA 
was prepared and its concentration determined as before (Part 
I, p. 19). Benzo(a)pyrene was dissolved in acetone and 3— 
hydroxyben2o(a)pyrene in absolute ethanol; the concentration 
of the latter then was determined by absorbance at 380 nm (e = 
30,800 W~^cm'~^), after which the ethanol was removed under 
argon and the residue was redissolved in 1.0 N NaOH. 
Retinoids and pyrenes were kept under argon, strictly out of 
white light, with gold fluorescent laboratory lights (Sylvania 
F40G0) serving as the only source of illumination. 
Preparation of Microsomes 
Fischer NHsd/344 female rats (Harlan Sprague-Dawley, 
Indianapolis, IN), 6—7 weeks old, were used upon arrival. 
Innovar-Vet^ (Pitman-Moore, Washington Crossing, NJ) was 
injected i.p. at 0.06 mL/100 g body weight. Excised livers 
were rinsed, minced, and homogenized in 250 mrt sucrose 
buffered with 15 m/f potassium phosphate, pH 7.4. The 
homogenate first was centrifuged for 20 min at 13,000 x g in a 
Beckman JA-20 rotor at 4°C, and then the resulting supernatant 
solution at 7 X 10^ g*min in a Beckman 80Ti rotor at 4°C; 
microsomes were washed once. The final pellet was suspended 
in 150 mM potassium phosphate, pH 7.4, or in 250 mM sucrose 
buffered with 10 mM Tris—maleate (pH 7.5 at 4°C). The 
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suspension was distributed into capped microcentrifuge tubes, 
which were then submerged in liquid nitrogen and subsequently 
stored at -70°C. Microsomal protein was measured by the 
method of Smith et al, (118), wherein BSA served as standard. 
Assay for Hannose—6—Phosphatase 
Mannose—6—phosphatase activity was measured in microsomes 
by a method based on that of Arion et al. (111). At a final 
volume of 0.1 mL, microsomes were preincubated on ice for 15 
min in 250 mW sucrose buffered with 5 mrt imidazole, pH 7.5, 
with detergent at specified concentrations, and with or 
without BSA or rat serum. Substrate solution (0.4 mL) was 
then added and the mixture was incubated in a shaking water 
bath at 37°C for 30 min. The final reaction mixture comprised 
10 mil M6P, 1 mff EDTA, 13 mW imidazole (pH 6.5), and 120 ug 
microsomal protein. Reaction was stopped by the addition of 
2.0 mL 10% trichloroacetic acid, and, after brief 
centrifugation, inorganic phosphate was measured by the method 
of Fiske and SubbaRow (119). 
Assay for Acyl CoA:Retinol 0—Acyltransferase 
The standard reaction mixture for ARAT assays comprised 20 
yW BSA, 5 mW dithiothreitol, 70 nW palmitoyl CoA, rat-liver 
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microsomes, and all—trans—retinol in 150 mf! potassium 
phosphate buffer, pH 7.4. Incubation, lasting 10 min, was 
performed in a shaking water bath at 37°C in the open air and 
under gold light. Retinoids were added in DMSO after the 
reaction mixture had been prewarmed for 2 min. Reaction was 
stopped by the addition of 1.0 mL cold absolute ethanol and 
the mixture was extracted with 1.5 mL hexane. The solvent was 
removed under argon and the residue was redissolved in 100 yL 
n-butyl acetate. Newly formed retinyl palmitate was separated 
from other retinyl esters and quantified by the reversed-phase 
HPLC system described before (Part I, p. 24). 
Assay for Benzo(a)pyrene Hydroxylation 
Hydroxylation of benzo(a)pyrene was assayed by a method 
modified after that of Nebert and Gelboin (120). The reaction 
mixture, with or without BSA at 1 mg/mL, contained 50 mW Tris— 
HCl buffer (pH 7.5 at 37°C), 3 mW MgClg, 720 uM NADPH, 64 jjW 
benzo(a)pyrene, and microsomal protein at 271 yg/mL, in a 
final volume of 0.25 mL. With 13-c-RA the mixture was warmed 
in a shaking water bath at 37°C for 2 min, at which time 
benzo(a)pyrene was added in 2 uL acetone. Incubation lasted 
30 min and was conducted in the open air under gold light. 
Reaction was stopped by the addition of 0.25 mL acetone, the 
mixture was extracted with 0.8 mL hexane, and the tube was 
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returned to the water bath for a 10—min incubation. A 0.25—mL 
aliquot of the organic phase was then extracted with 0.75 mL 
1.0 W NaOH; the alkaline extract was removed and diluted with 
2.0 mL 1.0 A/ NaOH. Fluorescence of the aqueous extract was 
measured with excitation at 396 nm and emission at 522 nm. 
The Spex fluorimeter was coupled to a Spex Datamate, with the 
photomultiplier tube water—cooled and the slit—width set at 
1.25 mm. Measurements were corrected for the presence of 13— 
c—RA in the alkaline extract, and a standard curve was 
generated for 3—hydroxybenzo(a)pyrene fluorescence in 1.0 N 
NaOH. 
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RESULTS AND DISCUSSION 
The activity of M6Pase in rat—liver microsomes was 
increased by 13—c-RA, 10% at 47 uM and 115% at 470 wM (Fig. 
1). In contrast, at 470 yM, palmitate stimulated hydrolysis 
only 33%, CHAPS 16%, all—t—RA 9%, and taurocholate 0%. 
Other amphiphiles also stimulate M6Pase in vitro (109-
111,121). In those reports, however, the activity in 
untreated microsomes varies from 5% to 35% of the maximal 
activity reported in the presence of detergent, probably 
depending on the way in which microsomes were prepared and 
stored. Thus, in a comparison of these results, the 
concentration of detergent giving maximal stimulation of 
M6Pase is more meaningful than the degree of stimulation for a 
given microsome preparation. Table 1 summarizes the results 
of current and past studies. Clearly, 13-c—RA is among the 
most active amphiphiles tested. This observation is in accord 
Table 1. Concentrations of amphiphiles that maximally 
stimulate mannose—6—phosphatase in rat liver 
Amphiphile Concentration (mM) Reference 
13—CIS—Retinoic acid 
Oleoyl CoA 
Deoxycholate 
Taurocholate 
CHAPSO 
0.30-0.47 
> 0.30 
3-3.8 
3.5-3.9 
3-4 
Present study 
1 1 0  
110  
1 1 1  
109 
Figure 1. Increase in mannose—6—phosphatase activity by 
amphiphilic compounds. Rat—liver microsomes (120 
us) were preincubated for 15 min at 0°C with 250 mM 
sucrose and 5 mM imidazole, pH 7.5, with 13—c—RA 
(O), all—t—RA (V), palmitate (O)i taurocholate (A), 
or CHAPS (o), at a final volume of 0.1 mL. 
Substrate solution was then added and M6Pase was 
assayed. Microsomes used were free of inorganic 
phosphate. Incubations were conducted as singlets, 
and the data are typical for several trials 
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Table 2. Protection by bovine serum albumin or rat serum 
against stimulation of mannose-6—phosphatase by 
13—cis—retinoic acid 
Additions 
to incubation 
Relative rate 
of M6P hydrolysis 
Absolute 
increase 
Relative 
increase 
None 1.00^ NA^ NA 
13-c-RA 2.14 114% 1.00 
13-C-RA + BSA 1.83 83% 0.73 
13-c-RA + rat serum 1.29 29% 0.25 
Rat-liver microsomes (120 yg protein) were preincubated 
for 15 min at 0°C with 13-c—RA at the specified 
concentrations, with or without BSA or rat serum at 2.3 mg 
protein/mL. At a final volume of 0.1 mL, preincubation 
solution also contained 250 mM sucrose buffered with 5 mil 
imidazole, pH 7.5. Substrate solution (0.4 mL) was then added 
and the final reaction mixture comprised 10 mW M6P, 1 mM EDTA, 
13 mW imidazole (pH 6.5), and microsomal protein at 240 yg/mL. 
After a 30—min incubation at 37°C, 2.0 mL 10% trichloroacetic 
acid was added and inorganic phosphate was measured by the 
method of Fiske and SubbaRow (119). Values are the means of 
duplicate trials, agreeing within 5%. 
^Absolute rate of 46 nmol inorganic phosphate 
released/min/mg microsomal protein. 
^"NA" = "not applicable". 
with that of Kon' et ai. (107), that 13-c-RA (and all-trans-
retinol), but not all-t-RA or particular synthetic retinoids, 
disrupted mitochondrial membranes at 525 yW. 
BSA or rat serum, when present in the preincubation of 
microsomes with 13—c—RA at 470 yW, attenuated the increase in 
membrane permeability to M6P (Table 2). In the presence of 
BSA at 2.3 mg/mL, the increase in M6Pase activity was only 73% 
of the increase without BSA. Under the same conditions and at 
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the same total concentration of protein, rat serum was even 
more protective, the increase being only 25%. Inasmuch as BSA 
can bind retinoic acid (122), it may lower the amount of 13-c— 
RA free to interact with the membranes. In serum, however, 
RBP (123), as well as albumin, lipoproteins, and possibly 
other serum components, may offer additional protection. 
Retinol esterification was inhibited in vitro by 13-c—RA 
(Fig. 2). Whereas 13-c-RA and all—t—RA behaved differently 
with respect to M6Pase (Fig. 1), they both inhibited ARAT, and 
to about the same extent (Fig. 2), even over a range of 
concentrations (Fig. 3). Thus, ARAT inhibition was 
independent of geometric configuration at C—13, while membrane 
disruption was much greater with the cis form. Data were fit 
to the Michaelis-Menten equation by means of the computer 
program of Oestreicher and Pinto (124). The calculated 
(319 pmol/min/mg microsomal protein without inhibitor) fell 
26% and 21% in the presence of all—t—RA and 13—c—RA, 
respectively. Without inhibitor, the value of was 19.9 yW, 
whereas it was 16.5 jjM with all—t—RA and 16.4 wW with 13-c-RA 
(Fig. 2A). A Hanes plot of the experimental data (Fig. 2B) 
gave similar results. From these data, then, the mechanism of 
inhibition is obscure, ostensibly a mixture of competitive and 
non—competitive interactions. 
At 32 jjW  retinol, the inhibition of ARAT rose 
progressively from 13% at 89 jjM 13—c—RA to 83% at 440 uM (Fig. 
Figure 2. Inhibition of retinol esterification by retinoic 
acid. Rat—liver microsomes (175 ug protein) were 
incubated with retinol in the absence (•) or 
presence of all—t—RA <•) or 13—C-RA (A) at 50 uM. 
(A) Relative rate of retinol esterification vs. 
retinol concentration. Reaction mixtures, at a 
final volume of 0.5 mL, contained 20 wM BSA, 5 mM 
dithiothreitol, 70 uM palmitoyl CoA, and retinol in 
150 mM potassium phosphate buffer, pH 7.4. 
Incubation lasted 10 min. (B) Hanes plot ([S]/v 
vs. [S]) of the data in A. Incubations were 
conducted as singlets, but the correlation 
coefficient for each line in B is > 0.99 
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Figure 3. Inhibition of retinol esterifIcation by retinoic 
acid at a fixed concentration of retinol. Rat-
liver microsomes were incubated with either all-
t—RA (•) or 13—c—RA (•), with retinol at 32 uW. 
Incubation conditions were otherwise the same as 
described for Fig. 2 
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4A). This inhibition follows a similar course as the 
stimulation of M6Pase (Fig. 1), with 50% ARAT inhibition and 
50% M6Pase stimulation occurring at about the same 
concentration of 13—c—RA (200 yW). Furthermore, ARAT 
inhibition and M6Pase stimulation reached plateaus in the same 
range of 13—c—RA concentrations. The degree of inhibition 
increased slightly with the time of preincubation of 
microsomes with 13—c—RA. With 13—c—RA at 222 jjW, ARAT was 
inhibited 51% without preincubation, whereas with 12-min 
preincubation the inhibition was 61%. These observations, 
along with the lack of a kinetically distinct mechanism of 
inhibition, are consistent with the notion that loss of 
membrane integrity played a large part in the inhibition of 
ARAT by 13-c-RA in vitro. 
Whatever the mechanism of ARAT inhibition, 13-C-RA in vivo 
is not likely to reach a concentration necessary for 
substantial inhibition in these in—vitro experiments, since 
the drug is not stored in the liver (125) and since the in-
vitro concentration of 13-c—RA has been shown merely to double 
upon massive dosing (106). The underlying biochemical 
problems with night vision reported in patients on therapy 
with 13—c—RA (112) probably do not involve ARAT in the liver. 
This conclusion is reinforced by studies demonstrating that 
the level of neither retinyl palmitate (106) nor total vitamin 
A (103) in rat liver is affected by dosing with 13-c—RA. 
Figure 4. Inhibition of retinol esterification and 
benzo(a)pyrene hydroxylation by 13-cis-retinoic 
acid. All reaction mixtures, at a final volume 
of 0.25 mL, contained rat—liver microsomes at 271 
vig protein/mL. (A) Relative rate of retinol 
esterification vs. 13—c—RA concentration. 
Retinol was present at 32 wM. ARAT was assayed 
otherwise as described for Fig. 2. (B) Relative 
rate of benzo(a)pyrene hydroxylation (BP) vs. 
13—c—RA concentration. BSA was either absent (•) 
or present O) at 1 mg/mL. Each datum is the mean 
for duplicate trials, each vertical bar enclosing 
the range 
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Benzo(a)pyrene hydroxylation, presumably catalyzed by aryl 
hydrocarbon hydroxylase (AHH) in these rat—liver microsomes, 
also was slower in the presence of 13—c-RA (Fig. 4B). With a 
rate of 120 pmol/min/mg microsomal protein without inhibitor, 
the inhibition was 31% and 62% with 13—c—RA at 44 and 440 yW, 
respectively. In contrast, Hill and Shih (126) reported that 
AHH in mouse— or hamster—liver microsomes was not inhibited in 
vitro by 13—c—RA. In that study, however, 13—c-RA was present 
in the reaction mixture at 50 pM, at which concentration none 
of the retinoids tested inhibited AHH by more than 15%. Fig. 
4B shows that inhibition was 35—40% at 50 yW 13—c—RA in the 
present study. Moreover, Hill and Shih included BSA in the 
reaction mixture at 1 mg/mL; as seen in Fig. 4B, though, BSA 
did not attenuate the inhibition in this system. 
Benzo(a)pyrene hydroxylation was inhibited by lower 
concentrations of 13—c—RA (< 100 uM) than was retinol 
esterification. Therefore, the apparent inhibition of AHH in 
vitro may bear greater physiological significance, although in 
one study the administration of 13—c-RA to rats did not change 
hepatic AHH activity subsequently assayed in vitro (127). 
Retinoids not only protect against damage by benzo(a)pyrene 
(114), but they also inhibit mixed—function oxidases (126), 
TCDD-induced lipid peroxidation (128), mutagenesis by 
quinoline (129), and formation of aflatoxin Bj—DNA adducts 
(130). 
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In smaller—scale experiments, two other retinoids also 
inhibited ARAT in vitro. Data for inhibition by N-(A-
hydroxyphenyDretinamide (HPR) and 15—methylretinol (MeROL) 
are shown in Fig. 5. For each retinoid, the linear 
transformation of the Michaelis—Menten equation giving the 
highest correlation coefficients was used. Inhibition by HPR 
displayed a competitive component (Fig. 5A), whereas 
inhibition by MeROL was strongly uncompetitive (Fig. 5B). In 
contrast, retinyl 6—D-glucuronide had no effect on ARAT in 
vitro at < 50 wW. Thus, ARAT's active site seems accessible 
to HPR but inaccessible to MeROL. Consistent with this 
conclusion, the data in Table 3 show that MeROL is not 
Table 3. Ineffectiveness of 15—methylretinol as a substrate 
for ARAT 
Substrate Concentration (jjM ) Relative rate^ 
Retinol 19 0.77 
38 1.00 
15—Methylretinol 15 0.06 
38 0.08 
^In 150 mW potassium phosphate buffer, pH 7.4, rat-liver 
microsomes (175 ug protein) were incubated with 20 wM BSA, 5 
mW dithiothreitol, and 75 wM palmitoyl CoA, with either 
retinol or 15—methylretinol, at a final volume of 0.5 mL. 
Incubation, at 37 C, lasted 10 min; reaction was stopped with 
ethanol, the mixture was extracted with hexane, and the 
extract was analyzed by reversed—phase HPLC. Values are means 
for duplicate trials, agreeing within 5%. 
Figure 5. Inhibition of ARAT in rat—liver microsomes by N—(4— 
hydroxyphenyl)retinamide and 15-methylretinol. (A) 
Lineweaver-Burk plot of data for inhibition by HPR. 
HPR was either absent (A) or present at 50 (•) or 
100 (o) wM. (B) Hanes plot of data for inhibition 
by MeROL. MeROL was either absent (A) or present 
at 23 (•) or 46 (o) yW. Incubation conditions were 
otherwise the same as described for Fig. 2 
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appreciably esterified by ARAT in vitro. These data lend 
further support to the physiological importance of ARAT in 
vivo in light of the report by Tosukhowong and Olson (117), 
showing the absence of significant esterification and storage 
of MeROL in the liver. 
Inasmuch as 13—c—RA disrupts membranes in the same range 
of concentrations at which it inhibits ARAT and AHH, any 
retinoid under evaluation as an in-vitro inhibitor of 
microsomal enmzymes should be evaluated also as a potential 
disruptor of membranes, especially at high concentrations. 
Thus, conclusions regarding the mechanism, and hence 
physiological relevance, of the in-vitro inhibition of 
microsomal enzymes by retinoids must consider the possibility 
that non-specific membrane disruption occurs simultaneously. 
Clearly, then, at least one therapeutic retinoid capable 
of inhibiting ARAT in vitro does so non-specifically, also 
inhibiting AHH and disrupting the microsomal membranes. In a 
physiological context, the ability of 13—c—RA to disrupt 
microsomes in vitro at concentrations where other amphiphiles 
have little or no effect should serve as a starting point for 
investigations into the mechanism of this drug's side—effects. 
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PART III. 
SPECIFICITY OF ACYL COENZYME A:RETINOL 0-ACYLTRANSFERASE 
TOWARD ITS FATTY-ACYL-CoA SUBSTRATE 
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INTRODUCTION 
As early as 1940 it was shown by Gray et al. (131) that, 
irrespective of its form, vitamin A fed to a rat was stored in 
the liver esterified with a small variety of fatty acids. In 
longer-term feeding experiments, however, Gray and Cawley 
(132) identified the predominant ester of vitamin A in rat 
liver as that of palmitic acid, with the range of fatty acids 
smaller than in the previous study. Subsequent reports 
confirmed these findings. As analyzed by Futterman and 
Andrews (2), the retinyl-ester fraction of the livers from 
eight species, human, rat, calf, sheep, rabbit, cat, frog, and 
trout, was mostly retinyl palmitate. The trio of palmitate, 
stearate, and oleate esters, moreover, accounted for no less 
than 70% of the total retinyl—ester concentration in all 
species except the frog, wherein they represented 64%. The 
predominance of retinyl palmitate in rat liver has been 
confirmed by Goodman et al. (22), Bhat and LaCroix (78), and 
Furr et al. (92). Although no retinyl oleate was detected in 
rat liver by Bhat and LaCroix (78), the palmitate/stearate/ 
oleate trio accounted for 71% of the retinyl esters in polar-
bear liver, with retinyl palmitate once again predominant 
(Part 1, p. 26, Table 2). Retinol esterification, then, may 
be a fatty—acid—specific process. 
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Surprisingly, Tomassi and Olson (94) saw no difference in 
the fatty-acid composition of hepatic retinyl esters among 
rats fed either 10% corn, linseed, or coconut oil for ten 
days. In a longer—term set of experiments, however, Furr et 
al. (93) fed rats synthetic simple triacylglycerols at 8% in 
the diet. Differences in the fatty—acid composition of 
dietary fat were reflected in the fatty-acid composition not 
only of retinyl esters in the liver but of total liver lipids 
as well. Thus, if retinol esterification is fatty-acid— 
specific, it can nonetheless accommodate gross changes in the 
fatty acids supplied as substrates. 
ARAT from various tissues uses several fatty—acyl—CoA 
thioesters as substrates, those tested being the stearoyl 
(1,56,58,59), oleoyl (1,55,56,58,59), linoleoyl (60), lauroyl 
(1,58), octanoyl (1,58), and, of course, palmitoyl 
(1,53,55,56,58-60,72,77) derivatives. No clear specificity 
for palmitoyl CoA has been demonstrated in ARAT from any 
tissue, although for liver (1) and small intestine (55,56) 
this derivative gives somewhat higher reaction rates. In 
fact, oleoyl and stearoyl CoA were better substrates for ARAT 
from lactating rat mamma (58), and were just as effective as 
palmitoyl CoA in the case of rat testis (59). 
Ideally, defining the specificity of an enzyme in vitro 
would be a simple matter of 1) incubating the enzyme with 
various competing substrates, present together in the reaction 
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mixture at equimolar concentrations, and then 2 )  calculating 
the ratio of k . to K for each, inasmuch as this ratio is 
cat m 
regarded as the true measure of a substrate's comparative 
effectiveness (133). However, fatty-acyl—CoA thioester 
derivatives are endogenous to rat-liver microsomes (134), and, 
as expected, they can serve as substrates for ARAT in in—vitro 
incubations (1). 
Because a net—synthesis assay for ARAT is used in the 
present investigation, approaches to the question of ARAT's 
in-vitro specificity toward its acyl—CoA substrate must 
address the complication of endogenous acyl CoA. Moreover, in 
previous experiments microsomes have been incubated with the 
various thioesters present singly, rather than together in 
substrate-competition studies. Questions about the 
complication of acyl CoA hydrolases, which may compete for 
substrate, and BSA, which binds oleoyl CoA in vitro (79), must 
also be settled. Finally, data on CoA thioesters of most 
polyunsaturated and odd—chain fatty acids as substrates for 
ARAT are absent from the literature, even though fatty—acyl 
groups of these kinds have been found in hepatic retinyl 
esters in vivo (2,22,78,92; Part I, p. 26, Table 2). 
The research described in this section considers these 
issues in defining the specificity of ARAT in vitro. For 
comparison, the specificity of ARAT from polar-bear liver also 
is examined. 
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EXPERIMENTAL PROCEDURE 
Materials 
Rebinai, retinyl palmitate, fatty—acyl—CoA thioester 
derivatives, DL-dithiothreitol, and BSA (essentially globulin-
and fatty—acid—free) were purchased from Sigma Chemical Co. 
(St. Louis, MO). All other chemicals and solvents were of the 
highest quality commercially available. all—trans—Retinol was 
prepared and its concentration determined as before (Part I, 
p. 19). Each fatty—acyl—CoA derivative was dissolved in 150 
mW potassium phosphate buffer, pH 7.4, and its concentration 
was determined by absorbance at 259.5 nm, with 6 = 15,400 
W~^cm~^. Solutions of each derivative were quick—frozen in 
liquid nitrogen and stored at —20°C, the unsaturated 
thioesters being sealed under argon. 
Preparation of Microsomes 
As before, differential centrifugation was used for 
preparing liver microsomes from rat (Part II, p. 44) and polar 
bear (Part I, p. 22). After being washed once, microsomes 
were suspended in 150 mW potassium phosphate, pH 7.4. The 
final microsome suspension was distributed into capped 
microcentrifuge tubes, which were then submerged in liquid 
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nitrogen and subsequently stored at —70°C. Microsomal protein 
was measured by the Bradford dye—binding method (90), with BSA 
serving as standard. 
Assay for Acyl CoA:Retinol 0—Acyltransferase 
The standard reaction mixture for ARAT assays comprised 20 
pW BSA, 5 mW dithiothreitoi, rat—liver microsomes, all-trans— 
retinol, and fatty—acyl—CoA thioesters in 150 mM potassium 
phosphate buffer, pH 7.4. Incubation, extraction, and HPLC 
analysis were performed as before (Part II, p. 46). 
General Protocol 
Attempts to define the specificity of ARAT in vitro 
employed two experimental approaches. By virtue of their 
design and rationale, which are described here, the results of 
these two approaches should be mutually consistent. 
In the first approach, microsomes were incubated with the 
exogenous fatty—acyl—CoA thioester derivatives to be tested as 
substrates, all together and equimolar in the reaction 
mixture. An apparent rate of formation was then calculated 
for each retinyl ester. However, for some retinyl esters this 
apparent rate included contributions from unknown amounts of 
acyl CoA endogenous to the microsomes. Therefore, a control 
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incubation, revealing how much of the apparent rate was 
attributable to endogenous substrate, was conducted for each 
retinyl ester. 
The control incubation contained all exogenous thioesters 
except the one whose endogenous contribution was being 
determined. For a given retinyl ester, this control rate was 
interpreted as the endogenous substrate's contribution to the 
rate observed in incubations containing all the exogenous 
acyl—CoA derivatives. Correcting for endogenous acyl CoA, 
then, consisted of subtracting the control rate from the 
apparent rate: 
^corrected ~ ^apparent ~ ^control 
where "v is the rate observed with all exogenous 
apparent 
acyl—CoA derivatives present in the reaction mixture, and 
"v . is the rate with all but the corresponding acyl-CoA 
control 
derivative present. 
Of course, omitting an acyl-CoA derivative from the 
reaction mixture would have lowered the total concentration of 
exogenous fatty—acyl CoA. Therefore, the total concentration 
of fatty-acyl CoA in the control incubations and those 
containing all exogenous derivatives were equalized. For 
example, rat—liver microsomes were incubated with 11 
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thioesters, each present at 5 uM, for a total exogenous 
concentration of 55 nM. 
The control incubation for, say, retinyl palmitate 
contained all exogenous derivatives except palmitoyl CoA, for 
a total exogenous concentration of only 50 yM. Any endogenous 
palmitoyl CoA in the control, then, would be competing with 
less total exogenous substrate than it would be in the 
incubation containing all thioesters, making the control rate 
deceptively high. Therefore, the concentration of each 
thioester in the control incubation for retinyl palmitate, 
from which palmitoyl CoA had been omitted, was made 5.5 viM to 
restore the total concentration of exogenous acyl CoA to 55 
jjW. Only when this adjustment is made are the control 
incubations valid. 
In the second approach to the problem of specificity, 
microsomes were incubated with a variety of exogenous fatty-
acyl—CoA derivatives, which had been added together and in 
equimolar amounts, at increasing total concentration. This 
approach assumes that as the total concentration of exogenous 
acyl CoA increases, the contribution from endogenous substrate 
should become less quantitatively important. Thus, a 
comparison of relative reaction rates at saturating 
concentrations of exogenous acyl CoA should provide insight 
into the specificity of ARAT in vitro without correcting for 
endogenous substrate. 
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Because of the limiting amount of sample available, 
experiments on the specificity of polar-bear-liver ARAT did 
not include control incubations for each retinyl ester, as in 
the first approach used for rat—liver ARAT. Instead, 
microsomes were incubated under three conditions: 1) in the 
absence of all exogenous acyl CoA, 2) in the presence of 
exogenous saturated derivatives, and 3) in the presence of a 
mixture of saturated and unsaturated derivatives. The 
"corrected" formation rate for a given retinyl ester was 
calculated by subtracting the rate when all exogenous 
substrate was absent from the rate when they were present. 
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RESULTS AND DISCUSSION 
Fatty-acyl-CoA thioesters are endogenous to microsomes 
(1,134), whether they associate with the membranes 
artifactually during cell fractionation or exist as such in 
vivo. Because calculating K for an acyl—CoA substrate 
m 
requires knowing its concentration in the reaction mixture, 
either the endogenous substrates had to be removed or their 
relative concentrations determined. 
In an effort to destroy the endogenous acyl CoA, 
microsomes were preincubated at 37°C with hydroxylamine, which 
reacts with acyl—CoA thioesters to give hydroxamates (65). 
Ross (1) was the first to use this approach for the purpose of 
removing endogenous acyl CoA from rat—liver microsomes. 
Inasmuch as adding palmitoyl CoA to reaction mixtures 
containing hydroxylamine-treated microsomes stimulated ARAT 
activity, ARAT in microsomes so treated was still active even 
though much of the endogenous acyl CoA had presumably been 
destroyed. 
In the present study, however, conditions for treatment 
with hydroxylamine that were required for rendering the 
endogenous acyl CoA negligible also resulted in a substantial 
loss of ARAT activity. So great was the loss, in fact, that 
when acyl—CoA thioesters were present together in incubations. 
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the reaction rate for each was too low to be measured 
accurately. 
Direct measurement of the endogenous acyl CoA also did not 
seem feasible. Whereas many methods for the extraction and 
analysis of acyl-CoA thioesters exist for various tissues and 
subcellular organelles (135-140), no technique for the 
extraction of these compounds from microsomes has been 
published. Because efforts to develop such a technique might 
have proven expensive and time—consuming, the approaches to 
defining the specificity of ARAT described under "General 
Protocol" were designed to circumvent the problem of 
endogenous substrate without compromising the quality of the 
data. 
When rat—liver microsomes were incubated with retinol in 
the absence of exogenous acyl CoA, six retinyl esters were 
formed: retinyl laurate, myristate, palmitate, stearate, 
oleate, and linoleate (Table 1). These rat—liver microsomes, 
then, ostensibly contained the lauroyl, myristoyl, palmitoyl, 
stearoyl, oleoyl, and linoleoyl derivatives of CoA. 
Although retinyl laurate and arachidonate do not co—elute 
with the HPLC system used here, the difference between their 
retention times is so small that these esters are identifiable 
only when both are present in a given run, in which case two 
clearly distinguishable peaks are observed. Inasmuch as 
arachidonic acid is much more abundant in rat liver than is 
Table 1. Comparison of formation rates for retinyl esters synthesized in vitro 
by rat—liver ARAT with their concentrations in vivo 
Percentage of total rate^ 
Reported percentage of total 
hepatic retinyl—ester concentration 
with all with no 
Retinyl ester 
exogenous 
acyl CoA 
exogenous 
acyl CoA^ Ref. 2 Reï. 22^^ Réf. 70 Réf. 92® 
Laurate 6.0 3.8. NRf'9 NR 1.2 0.9& 
Tridecanoate 11.0 ND  ^ NR NR NR NR 
Myristate 10.3 4.9 0.3 NR 2.1 0.73 
Pentadecanoate 11.0 ND 0.7 NR 1.6 1.4 
Palmi tate 12.0 38.2 69.0 74.6 79.2 79.5 
Heptadecanoate 13.3 ND 2.7 NR 2.2 1.2 
Stearate 10.4 38.5 15.1 13.4 6.9 8.4 
Arachidate 9.7. ND NR NR NR ND . 
Palmi toleate NT ND 2.0 NR 3.7 O.7J 
Oleate 14.2 8.8 5.9 7.4 ND 2.8 
Linoleate 1.7 5.8 1.4 4.8 2.9 4.9 
Linolenate NT ND NR NR NR 0.3 
Arachidonate 0.6 ND NR NR NR 0.9  ^
^Reaction mixtures comprised rat—liver microsomes at 237 yg protein/mL, 20 
ViW BSA, 5 mM dithiothreitol, 37 jjJI retinol, and fatty—acyl—CoA thioester 
derivatives in 150 mW potassium phosphate buffer, pH 7.4. Incubation, at 37°C, 
lasted 10 min; reaction was stopped with ethanol, the mixture was extracted with 
hexane, and the extract was analyzed by reversed—phase HPLC. Values are means 
for duplicate trials, agreeing within 5%. 
^Eleven exogenous fatty—acyl—CoA thioester derivatives (lauroyl, 
tridecanoyl, myristoyl, pentadecanoyl, palmitoyl, heptadecanoyl, stearoyl, 
arachidoyl, oleoyl, linoleoyl, and arachidonoyl) were included in the reaction 
mixture, each at 5 uW. See "General Protocol" for details; this rate is the same 
^corrected' 
^No exogenous fatty—acyl CoA was present in the reaction mixture. 
"^Mean for rats identified in the report as "D" through "K". 
^Ref. 92 was consulted in conjunction with a personal communication from the 
first author, H. C. Furr, Dept. of Biochemistry and Biophysics, Iowa 
State University, Ames, Iowa. 
^"NR" = "not reported". 
^The authors note that "small quantities of laurate, myristoleate, and 
several unidentified components were present". 
^Retinyl laurate and arachidonate co—eluted in this system. 
^"ND" = "not detected". 
^Retinyl myristate and palmitoleate co—eluted in this system. 
"NT" indicates that the corresponding acyl CoA derivative was "not tested" 
as a substrate. 
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lauric acid (141,142), what has been called retinyl laurate in 
these studies, may, in reality, be the arachidonate ester. 
Finding thioesters of CoA with C^g and C^g fatty acids 
endogenous to the microsomes is expected. These compounds are 
substrates for the enzymes in the endoplasmic reticulum that 
elongate palmitic acid to stearic and desaturate stearic acid 
to oleic, as well as those that synthesize arachidonic acid 
from linoleic (143). However, the presence of CoA thioesters 
of lauric and myristic acids is puzzling inasmuch as these two 
fatty acids occur in hepatic lipids in very small amounts 
relative to other fatty acids (141,142). Even in rats 
maintained on diets 10% in coconut oil, which is rich in 
lauric and myristic acids, the concentration of these acids in 
lipids of the liver was remarkably low (141). 
Indeed, finding arachidonoyl CoA in the microsomes along 
with linoleoyl CoA would be consistent with the role of 
endoplasmic reticulum in the elongation and desaturation of 
fatty acids. Nonetheless, the retinyl—laurate peak has been 
so identified primarily because, as also shown in Table 1, it 
was formed by ARAT at a 10—fold higher rate than was retinyl 
arachidonate when rat—liver microsomes were incubated with the 
corresponding acyl—CoA thioesters. However, whether the peak 
is retinyl laurate or arachidonate, it represents less than 1% 
of the total retinyl—ester concentration in vivo (Table 1). 
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Retinyl myristate and palmitoleate have similar retention 
times also. Although what has been identified as retinyl 
myristate may have been retinyl palmitoleate, both of these 
esters have been found in the liver, and in larger amounts 
than retinyl laurate or arachidonate (Table 1). 
Table 1 shows the results of experiments in which 
exogenous fatty—acyl—CoA thioesters were present together at 
equimolar amounts in the reaction mixture with rat—liver 
microsomes. Corrected for contributions from endogenous 
substrate, the percentages of the total rate of reaction for 
the various derivatives are listed as the first column of 
numbers. Clearly, all tested thioesters of saturated fatty 
acids from C to Cgg were effective substrates for ARAT in 
vitro, although the rate for lauroyl CoA was only about 45% of 
the maximum in the saturated series, observed for 
heptadecanoyl CoA. Whereas oleoyl CoA was the most effective, 
the thioesters of linoleic and arachidonic acids were poor 
substrates for ARAT. 
Whereas lauroyl CoA was only 50% as effective a substrate 
as palmitoyl CoA, Ross (1) reported it to be 92% as effective. 
Furthermore, the reaction rates for stearoyl and oleoyl CoA 
were 87% and 118%, respectively, of that for palmitoyl CoA in 
the present study, in contrast to 71% and 89%, respectively, 
in Ross' (1) experiments. Octanoyl CoA, not tested in the 
present study, gave a rate only 58% of that for palmitoyl CoA 
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(1). In explaining these discrepancies, two differences in 
design between the two experiments must be noted: 1) Ross (1) 
incubated microsomes with only one CoA derivative at a time, 
and 2) with each derivative at a concentration roughly twice 
the total concentration used in the present study; these 
differences in design may have translated into significant 
differences in results. 
Reported critical micelle concentrations for these 
derivatives vary enormously with chain length from 7.5 uW for 
stearoyl CoA to 1130 yW for lauroyl CoA (144—145), and with 
ionic strength and the nature of the buffer (145). Whereas 
micelles of these CoA thioesters were presumably homogeneous 
in Ross' (1) reaction mixtures, in the present study they were 
likely to be mixed, though uniform in both size and 
composition. Accessibility of the fatty—acyl—CoA substrate to 
ARAT, therefore, may have been different in Ross' (1) study 
than in the present one. 
An additional complication lies in the ability of BSA to 
bind oleoyl CoA in vitro (79), and perhaps other such 
thioesters also. While micelles undoubtedly differed between 
these experiments, binding of acyl CoA to BSA also may have 
differed, affecting substrate accessibility further. The 
kinetics of enzyme-catalyzed reactions for which acyl CoA is a 
substrate and BSA is included in the reaction mixture are 
inherently uncertain because studies on the partitioning of 
Figure 1. Relative formation rates for retinyl esters at 
increasing concentration of total acyl CoA. Rat— 
liver microsomes were incubated at 37°C with 
lauroyl (12:0), myristoyl (14:0), palmitoyl 
(16:0), stearoyl (18:0), and oleoyl (18:1) CoA, 
added together and in equimolar amounts. 
Reaction mixture contained 20 uM BSA, 5 mM 
dithiothreitoi, 48 uM retinol, and microsomal 
protein at 350 vig/mL. Incubation lasted 10 min. 
Each datum is the mean of duplicate trials, each 
vertical bar enclosing the range 
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acyl-CoA thioesters among the monomer, micelle, and BSA—bound 
forms are absent from the literature (146). 
In the second approach to defining the specificity of 
ARAT, microsomes were incubated with five exogenous acyl—CoA 
derivatives, present together and in equimolar amounts, at 
increasing total concentration. As seen in Fig. 1, the 
palmitate and stearate esters of retinol were formed in 
greatest quantity when exogenous acyl CoA was absent from the 
reaction mixture, in general agreement with Table 1. As the 
total concentration of exogenous acyl CoA increased to 
apparent saturation (Fig. 2), endogenous substrate was 
progressively diluted. The rates for palmitoyl, stearoyl, and 
oleoyl CoA tended to equalize, while those for lauroyl and 
myristoyl CoA stayed lower (Fig. 1). 
This approach was used also for testing polyunsaturated 
derivatives as substrates for ARAT. Microsomes were incubated 
with palmitoyl, stearoyl, oleoyl, linoleoyl, linolenoyl, and 
arachidonoyl CoA under the same conditions as described for 
Fig. 1. Whereas the formation rates for retinyl palmitate, 
stearate, and oleate tended to equalize as the total 
concentration of exogenous acyl CoA increased, the sum of the 
formation rates for retinyl linoleate, linolenate, and 
arachidonate was less than 1% of the total rate at any 
concentration. 
Figure 2. Rate of retlnyl ester formation as a function of 
the concentration of exogenous acyl CoA. Details 
are the same as those for Fig. 1. 
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Despite differences in experimental design, the 
fundamental conclusions emerging from the two approaches to 
the question of specificity in the present study are the same: 
1) even under conditions of substrate competition, ARAT from 
rat liver can transacylate retinol with a variety of fatty-
acyl—CoA derivatives, saturated, monounsaturated, even— or 
odd—chain, and 2) CoA thioesters of polyunsaturated fatty 
acids are poor substrates. 
Conclusions from these specificity studies assume that the 
activity of other microsomal enzymes for which fatty—acyl—CoA 
thioesters are substrates is negligible under the conditions 
of these experiments. Inasmuch as retinol was present in the 
system in great excess over all other reactants except water, 
the only potentially competing reaction was hydrolysis of the 
acyl—CoA thioesters. Fortunately, directly measuring the 
hydrolysis to assess its quantitative importance was 
unnecessary inasmuch as Mg ^-ion could be used to inhibit 
hydrolase activity in the reaction mixtures (147,148). 
Neither the total rate of retinol esterification nor the 
percentage thereof for a given acyl—CoA thioester was affected 
24. 
by Mg (Table 2). Microsomal fatty—acyl—CoA hydrolases, 
then, did not confound the results of specificity experiments 
by competing with ARAT for substrate in vitro. Although only 
saturated derivatives were used to generate the data in Table 
2, the dismissal of microsomal thioesterases as competing 
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Table 2. Effect of inhibiting microsomal acyl CoA hydrolase 
activity on relative formation rates of retinyl 
esters 
Retinyl ester 
Percentage of total rate^ 
wi thout 
acyl 
exogenous 
CoA 
with exogen 
acyl CoA 
ous 
-Mg^+ +Mg=+ -Mg2+ 2 + +Mg 
Laurate ND^ ND 6.4 6.0 
Tr idecanoate ND ND 9.2 9.5 
Myristate ND ND 15.0 14.6 
Palmitate 47.5 47.7 38.8 38.5 
Stearate 49.3 48.8 30.6 31.4 
Oleate ^ 3.2 3.5 < 1 < 1 
Linoleate < 1 < 1 ND ND 
^In potassium phosphate buffer, pH 7.4, at a final volume 
of 0.5 mL, rat—liver microsomes (150 ug protein) were 
incubated with 20 uM BSA, 5 mW dithiothreitol, and 52 uM 
retinol, with or without exogenous acyl CoA. The 
concentration of MgClg, when present, was 6 pW. Incubation, 
extraction, and analysis procedures were the same as described 
under Table 1. Values are means of duplicate trials, agreeing 
within 5%. 
^Lauroyl, tridecanoyl, myristoyl, palmitoyl, and stearoyl 
CoA, each present in the reaction mixture at 4 jjM. 
'^"ND" = "not detectable". 
"^Corresponding acyl CoA was not included in exogenous 
mixture of acyl—CoA substrates. 
enzymes can be extended to the unsaturated thioesters also 
because 1) Mg ^  did not change the relative formation rate of 
retinyl palmitate even though palmitoyl CoA is a much better 
substrate for the hydrolases than other thioesters, including 
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oleoyl CoA (148,149), and 2) Mg ^  would have increased the 
relative formation rate of retinyl linoleate in the absence of 
exogenous substrate if the hydrolases had been competing with 
ARAT for linoleoyl CoA. 
Like the microsomal thioesterases under the conditions of 
these specificity experiments, BSA in the reaction mixture did 
not interfere with interpretation of the results. Changing 
the concentration of BSA ata fixed concentration of exogenous 
acyl coA was accompanied by small, but physiologically 
Table 3. Effect of changing the ratio of BSA to acyl CoA on 
relative formation rates of retinyl esters 
Percentage of total rate^ 
Retinyl ester 
30 un acyl CoA 60 yW acyl CoA 
-BSA +BSA -BSA +BSA 
Laurate 5.3 6.0 5.8 7.1 
Tridecanoate 9.3 9.9 8.9 10. 2 
Myristate 11.0 11.5 11.5 9.6 
Palmi tate 24.5 22.6 25.4 26.9 
Stearate 24.0 22.9 25.0 25.3 
Oleate 24.8 26.3 22.1 19.1 
Linoleate 1.1 0.8 1.3 1.8 
^In potassium phosphate buffer, pH 7.4, at a final volume 
of 0.5 mL, rat-liver microsomes (150 ug protein) were 
incubated with 5 mW dithiothreitol, 52 uN retinol, and 
exogenous acyl CoA. The concentration of BSA, when present, 
was 20 uM. Lauroyl, tridecanoyl, myristoyl, palmitoyl, 
stearoyl, oleoyl, and linoleoyl CoA were present together in 
the reaction mixtures at equimolar concentrations. Values are 
means of duplicate trials, agreeing within 5%. 
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insignificant, changes in the relative reaction rate for a 
given acyl—CoA derivative (Table 3). 
The fatty—acid composition of retinyl esters in vivo is 
not reflected in the specificity of ARAT for its fatty-acyl-
CoA substrate in vitro. Whereas the specificity of ARAT fails 
to account for the predominance of retinyl palmitate among 
esters of vitamin A in rat liver, it does accord with the 
relatively small amount of polyunsaturated esters (Table 1). 
The possible explanations for this discrepancy between 
specificity and composition are tied to the physiological 
implications, ultimately raising questions about the role of 
ARAT in the synthesis of retinyl esters in the liver. 
Retinyl ester hydrolase (REH; EC 3.1.1.21) is the enzyme 
that hydrolyzes retinyl esters to mobilize retinol from liver 
reserves (150—153). In hydrolyzing retinyl palmitate more 
slowly than other esters of retinol, this enzyme would offer 
an alternate explanation for the predominance of retinyl 
palmitate in vivo. However, Mahadevan et al. (150) found that 
retinyl palmitate was preferred by REH from rat liver, the 
rate being at least twice that for any other ester. Moreover, 
Cooper and Olson (153), studying REH in pig liver, reported an 
intermediate rate of hydrolysis for retinyl palmitate: 
linolenate > myristate > palmitate > oleate > linoleate > 
stearate. Thus, inasmuch as REH does not discriminate against 
retinyl palmitate as a substrate in vitro, invoking the 
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specificity of this enzyme to explain the predominance of 
retinyl palmitate in vivo is not helpful. Furthermore, when 
the specificities of ARAT and REH in vitro are Juxtaposed, 
retinyl palmitate is expected to be among the least abundant 
retinyl esters in vivo. 
An alternative to enzyme specificity as an explanation for 
the fatty—acid composition of retinyl esters is the 
possibility that palmitoyl CoA occurs in greater concentration 
at the intracellular site of retinol esterification than do 
other CoA thioesters. In partial support of this hypothesis, 
the data in Table 1 and Fig. 1 strongly suggest that fatty-
acyl—CoA thioesters in microsomes are those of palmitic, 
stearic, and oleic acids; the retinyl esters formed by rat-
liver microsomes in the absence of exogenous acyl CoA were 
palmitate, stearate, and oleate, as mentioned before. 
After Drevon et aJ. (68) incubated rat—liver cells with 
retinol in culture, retinyl palmitate accounted for about 75% 
of the retinyl—ester fraction, whereas the stearate and oleate 
esters were only 10% and 4%, respectively. The contribution 
of retinyl oleate, however, rose to 13% when oleic acid was 
added to the culture medium. Ross et ai. (154) found that the 
pattern of fatty acids in the retinyl—ester fraction of rat 
milk reflected the fatty-acid composition of the diet. Even 
trans fatty acids appeared in the retinyl esters of milk from 
rats fed hydrogenated corn oil. 
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In whole-animal experiments, Furr et al. (93) recently 
demonstrated the influence of the composition of dietary fatty 
acids on the composition of retinyl esters in vivo. Rats were 
fed a diet 8% in a synthetic simple triacylglycerol or corn or 
partially—hydrogenated soybean oil for 23 days. Although 
retinyl palmitate remained dominant, the proportion of retinyl 
stearate or oleate increased when rats were fed tristearin or 
triolein, respectively. Whereas feeding rats trilinolein 
increased the proportion of retinyl linoleate, it decreased 
the total concentration of retinyl esters in the liver, 
consistent with the observation that CoA thioesters of 
polyunsaturated fatty acids are poor substrates for ARAT 
(Table 1). Likewise, feeding rats corn or partially— 
hydrogenated soybean oil enriched the retinyl esters in 
polyunsaturated fatty acids. 
These studies have firmly established a link between the 
supply of fatty acids to the cell and the composition of 
retinyl esters. Thus, although several CoA thioesters are 
effective substrates for ARAT, the synthesis of retinyl 
palmitate in vivo is favored perhaps by the presence of 
palmitoyl CoA at a concentration higher than that of other 
derivatives in the microenvironment of ARAT. De—novo fatty-
acid biosynthesis, along with subsequent elongation and 
desaturation by enzymes in the endoplasmic reticulum, 
contribute to the liver's pool of fatty acids. It is well-
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known that the major products of these processes in mammals 
are palmitic, stearic, and oleic acids, the three most 
abundant ones in the retinyl—ester fraction of the liver 
(Table 1; Part I, p. 26, Table 2). 
Inconsistency between the specificity of ARAT and the 
fatty—acid composition of retinyl esters was seen also for 
polar—bear liver (Table 4). Although the experimental 
approach .differed slightly from that used for rat liver (see 
"General Protocol", pp. 70—73), the specificities of hepatic 
ARAT from the rat and the polar bear were very similar, except 
that the bear enzyme displayed a greater preference for oleoyl 
CoA than did the rat enzyme. The proportion of retinyl oleate 
and linoleate were higher in the bear liver than in rat liver, 
although retinyl palmitate predominated in both (Tables 1 and 
4). In light of the results of Furr et ai. (93), the fatty 
acids of the smelt in this bear's diet may have had an impact 
on the composition of retinyl esters in the liver; the fact 
that fish oil is rich in unsaturated fatty acids is common 
knowledge. 
Discrepancies between specificity in vitro and composition 
in vivo are not unique to ARAT. An example of another 
acyltransferase for which such a discrepancy exists is ACAT, 
the analogous enzyme in cholesterol esterification. For this 
enzyme, oleoyl, palmitoyl, and stearoyl CoA are effective 
substrates, while linoleoyl CoA is less so (67). However, in 
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Table 4. Comparison of formation rates for retinyl esters 
synthesized in vitro by polar—bear—liver ARAT with 
their concentrations in vivo 
Percentage of 
total rate 
Retinyl ester 
saturate^ 
acyl CoA 
saturated + 
unsaturated 
acyl CoA*^ 
Percentage of 
total hepatic 
retinyl-ester^ 
concentration 
Laurate 4.6 NI® 2.1 
Tridecanoate 7.2 5.4 NR^ 
Myristate 13.5 NI 2.0 
Pentadecanoate 11.4 9.0 1. 7 
Palmi tate 14.5 18.5 37.3 
Heptadecanoate 13.3 8.6 2.6 
Stearate 9.5 9. 7 12.8 
Nonadecanoate 10.7 NI NR 
Arachidate 10.4 8.2 NR 
Behenate 5.0 4.1 NR 
Oleate NI 31. 7 20.9 
Linoleate NI 4.6 7.7 
Linolenate NI 0.3 NR 
^Reaction mixtures comprised polar—bear—liver microsomes 
(315 jjg protein/mL) , 15 uM BSA, 5 mW di thiothreitol, 80 jjW 
retinol, and fatty—acyl—CoA thioesters in 150 mW gotassium 
phosphate buffer, pH 7.4. After incubation at 37 C, reaction 
was stopped with ethanol, the mixture was extracted with 
hexane, and the extract was analyzed by reversed—phase HPLC. 
Values are means of duplicate trials, agreeing within 5%. 
^The 13 corresponding saturated exogenous fatty-acyl-CoA 
thioesters were included in the reaction mixture, each at 10 
mW. See "General Protocol" for details. 
^The 10 corresponding fatty—acyl—CoA thioesters, 
saturated and unsaturated, were included in the reaction 
mixture, each at 10 wW. See "General Protocol" for details. 
'^Values in Table 2, Part I, p. 26, are reproduced here. 
= corresponding acyl CoA "not included" in mixture. 
^"NR" = "not reported". 
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rat—liver homogenates cholesteryl oleate and linoleate 
predominate, together accounting for nearly 60% of the total 
cholesteryl esters (67). 
Another example is acyl CoA: estradiol 17—6—acyltransferase 
(EC 2.3.1...), from bovine placental cotyledon. Whereas 
palmitoyl CoA is an effective substrate for this enzyme, 
estradiol in vivo is esterified mainly with polyunsaturated 
fatty acids (155). Like ARAT, both this enzyme and ACAT are 
membrane—bound also, and the effective substrate concentration 
in their microenvironments may likewise influence the fatty-
acid composition of the lipids they acylate in vivo. 
Another explanation for the discrepancy between the 
specificity of ARAT in vitro and the fatty—acid composition of 
retinyl esters in vivo is the existence of a second retinol-
acylating enzyme in the cell. Although ARAT has been 
characterized in the small intestine (55,56), an acyl-CoA-
independent enzyme that esterifies retinol has been identified 
in small—intestinal microsomes by Ong et ai. (15). When these 
microsomes were incubated with retinol bound to CRBP(II), the 
retinyl esters formed, in order of descending percentage of 
the total formed, were palmitate, stearate, oleate, and 
linoleate. As mentioned before (Part I, p. 36), whereas 
little fatty—acid-specificity was seen for ARAT from small 
intestine (55,56), the ester proportioning observed with the 
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acyl—CoA—independent reaction was very similar to that found 
in chylomicrons (156) and whole lymph (157). 
Futterman and Andrews (2) published the only data in the 
literature hinting at the existence of another retinol-
acylating enzyme in the liver. When cat—liver microsomes were 
incubated with retinol, two pH optima were seen, one about 4.5 
and the other about 8.2. At the latter pH the composition of 
retinyl esters synthesized in vitro resembled that of retinyl 
esters in vivo. Although Ross (1) did not report precisely 
how ARAT activity in vitro varied with pH, the pH of all 
reaction mixtures in those experiments, and in the present 
study, was 7.4. Furthermore, Futterman and Andrews (2), like 
Ong et al. (15), saw no requirement for fatty acids activated 
with CoA. In the light of Futterman and Andrews' (2) report, 
the data on the specificity of ARAT in vitro (Tables 1 and 4, 
Fig. 1) call for investigation into the possible existence of 
a second retinol—acylating enzyme in the liver. 
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GENERAL DISCUSSION 
The research described in the preceding three sections 
addresses certain questions surrounding the ARAT-catalyzed 
transacylation of retinol that have been raised, but left 
unattended, by the biochemical literature. The fundamental 
novel findings in this work are 1) that ARAT is present in 
polar—bear liver and that some of its properties are different 
from those of rat-liver ARAT, 2) that the fatty-acid 
composition of retinyl esters in polar—bear liver is similar 
to that in other species, 3) that rat mammary tumor also 
apparently contains ARAT activity, 4) that ARAT activity in 
both this tumor and rat liver is enhanced in response to 
administration of vitamin A to the animal, 5) that various 
retinoids, including 13—c—RA, can inhibit ARAT in vitro, 6) 
that 13-c-RA also inhibits benzo(a)pyrene hydroxylation and 
disrupts microsomal membranes in vitro, 7) that MeROL is not 
an effective substrate for ARAT in vitro, 8) that saturated 
C12-C20 fatty-acyl—CoA thioesters, even- or odd-chain, are 
effective substrates for rat—liver ARAT in vitro whereas 
polyunsaturated derivatives are not, and 9) that the acyl—CoA 
specificity of ARAT from rat and polar bear are similar. 
With characterization of ARAT in polar—bear liver, a 
marine mammal joins the growing list of species in which the 
enzyme has been identified: other mammals, including the human 
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(53,56), rat (1,55,58,59), lamb (57), and mouse (60), and at 
least one non—mammal, the chick (54). Thus, ARAT may be 
ubiquitous in the animal kingdom. Furthermore, rat mammary 
tumor joins the growing list of tissues with ARAT activity: 
the liver (1,53,56), small intestine (55,56), kidney (57), 
mamma (58), testis (59), and epidermis (60). Assigning a 
physiological role to the ARAT—catalyzed reaction is justified 
by I) the high activity of ARAT in polar-bear liver (Part I, 
p. 27), a tissue with unusually large amounts of retinyl ester 
(74,75; Part I, p. 25), 2) its low activity in rat mammary 
tumor, a tissue with negligible amounts (88; 0. Amedee—Manesme 
and H. C. Furr, Dept. of Biochemistry and Biophysics, Iowa 
State University, Ames, Iowa, personal communication), 3) its 
enhancement in tumor (Part I, pp. 35—36) and in liver (72,73; 
Part I, pp. 35-36) by dosing with vitamin A, and 4) its 
inability to use MeROL (Part II, p. 61) or polyunsaturated 
acyl—CoA thioesters as substrates in vitro (Part III, p. 86), 
in that MeROL is not esterified or stored in the liver (117) 
and polyunsaturated retinyl esters occur only in small amounts 
(Part III, pp. 76-77, Table 1). This is in keeping with the 
report of Blomhoff et al. (158), demonstrating ARAT at very 
high specific activity in the stellate cells of the liver, the 
cells in which 80—90% of hepatic vitamin A is stored (159). 
Olson (160) has proposed that ARAT has a "key role" in retinol 
ester ification in vivo. 
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The physiological relevance of the inhibition of ARAT in 
vitro by various retinoids (60,62,77; Part II, pp. 52,61) 
depends on the specificity of the in-vitro effects of the 
inhibitor. For example, although 13—c—RA inhibited ARAT in 
vitro, it did so only at physiologically unreasonable 
concentrations (Part II, p. 57), and not without inhibiting 
benzo(a)pyrene hydroxylation also (Part II, p. 60), as well as 
rendering the microsomes "leaky" (Part II, p. 48). 
The molecular specificity displayed by 13—C-RA in 
disrupting membranes was striking (Part II, p. 48). Even all-
t—RA, which inhibited ARAT to about the same extent as 13—C-RA 
(Part II, pp. 54,56), had much less effect on the integrity of 
the microsomes in vitro (Part II, p. 48). In the retinoic 
acids, then, are found two retinoids that inhibit ARAT in 
vitro, one increasing membrane permeability (13—c—RA) and the 
other not (all—t-RA). The possibility that 13-c-RA, as a 
drug, also disrupts membranes in vivo should now be explored. 
One explanation for the discrepancy between the fatty-acid 
composition of retinyl esters in vivo and the specificity of 
ARAT for its acyl-CoA substrate in vitro is a localized high 
concentration of palmitoyl CoA in the microenvironment of ARAT 
in the endoplasmic reticulum (Part III, p. 90). An experiment 
for testing this hypothesis should consider the possibility 
that ARAT is somehow linked to fatty-acid biosynthesis, 
perhaps simply by being in close proximity to the microsomal 
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enzymes that ligate to CoA the palmitate newly synthesized by 
fatty—acid synthase. 
1 A C—labelled fatty acid used less than others for 
retinyl—ester synthesis in vivo, but one that can be elongated 
to palmitate by fatty-acid synthase, e.g., lauric, may be 
injected intravenously into nutritionally normal rats. After, 
say, two weeks, the livers are removed. Hepatic retinyl 
esters are separated by chain—length, and the peaks are 
collected and counted. By examining the distribution of label 
in the fatty acids of the retinyl—ester fraction, the 
importance of fatty-acid biosynthesis to retinol 
esterification is determined. If label is found only in 
retinyl palmitate, stearate, and oleate, the conclusion would 
be that palmitic acid was synthesized, elongated, and 
desaturated before retinol was esterified. However, finding 
most of the label in retinyl laurate, or finding a roughly 
equal proportioning between that ester and longer ones, would 
imply that ARAT does not depend on fatty-acid biosynthesis for 
a supply of substrate. This conclusion, moreover, would argue 
for the possible existence of a second retinol—acylating 
enzyme in the liver. Indeed, an acyl—CoA—independent retinol-
acylating enzyme, whose characteristics are similar to those 
of the analogous enzyme in small intestine (15), has recently 
been discovered (D. E. Ong, P. N. MacDonald, and A. M. 
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Gubîbosi, Dept. of Biochemistry, Vanderbilt University, 
Nashville, Tennessee, personal communication). 
In the search for a second enzyme, retinol bound to 
hepatic cellular retinol—binding protein may be incubated with 
rat-liver microsomes, as Ong et ai. (15) did for small 
intestine. If retinol is esterified under these conditions, 
if the reaction is not accelerated by the addition of acyl 
CoA, and if the fatty-acid composition of the retinyl esters 
formed reflects that of retinyl esters stored in vivo, 
microsomal lipids should be extracted on a large scale and 
then fractionated by thin—layer chromatography. After zones 
are scraped off the plate into an organic solvent, the 
fractions are saponified, the fatty acids are methylated, and 
the methyl esters formed are analyzed by gas—liquid 
chromatography. Fractions with a fatty-acid profile similar 
to that of the retinyl esters formed are the first to be 
considered putative substrates in the acyl—CoA—independent 
esterification of retinol. This approach, of course, may 
entail elucidating the positional fatty—acid composition of 
each lipid fraction, inasmuch as the enzyme may be restricted 
to the fatty acids at a particular position on the glycerol 
backbone. 
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CONCLUSIONS 
1. The transacylation of retinol by ARAT in vivo is 
physiologically significant. This conclusion is based on the 
observations that 1) ARAT activity is unusually high in polar-
bear liver, a tissue that stores retinyl esters in 
exceptionally large amounts, 2) ARAT activity is very low in 
rat mammary tumor, a tissue that contains virtually no vitamin 
A, either as retinyl esters or retinol, 3) ARAT activity is 
enhanced in both tumor and liver in response to dosing with 
vitamin A, and 4) 15—methylretinol, which is not esterified or 
stored in the liver, is not an effective substrate for ARAT in 
vitro. 
2. Some properties of ARAT from polar—bear liver differ 
markedly from those of rat—liver ARAT. Whereas both BSA and 
dithiothreitol markedly stimulated rat-liver ARAT in vitro, 
bear—liver ARAT was almost independent of these incubation 
supplements. 
3. Although ARAT is inhibited in vitro by various 
retinoids, studies in which retinoids are evaluated as in-
vitro inhibitors of ARAT should also examine the effects of 
these compounds on other microsomal enzymes or on the 
integrity of the membranes themselves. 13—cis—Retinoic acid, 
which inhibited ARAT in vitro, not only inhibited 
benzo(a)pyrene hydroxylation also, but increased the 
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permeability of the microsomal membranes to mannose-6-
phosphate, as evidenced by a rise in the activity of mannose— 
6-phosphatase. The inhibition of benzo<a)pyrene hydroxylation 
in vitro by 13—els—retinoic acid, because it occurred at lower 
concentrations, may be more physiologically significant than 
the inhibition of retinol esterification. 
4. The side—effects of 13—cis—retinoic acid, which is a 
drug used at high doses in the treatment of recalcitrant acne, 
may be mediated in vivo by membrane disruption. 13-cis-
Retinoic acid increased the permeability of microsomes to 
mannose—6—phosphate at concentrations where four other 
amphiphiles were much less effective: palmitate, 3-
[(cholamidopropyl)—dimethyl—ammonio]—l—propane sulfonate, all— 
trans—retinoic acid, and taurocholate. 
5. Retinol esterification in the liver may be catalyzed 
by more than one enzyme. The specificity of ARAT for its 
fatty—acyl—CoA substrate in vitro fails to account for the 
fatty—acid composition of retinyl esters in vivo. Whereas 
oleoyl CoA and CoA thioesters of Cgo saturated fatty acids 
are effective substrates for ARAT, retinol exists in the liver 
mainly as the palmitate ester, with lesser amounts of retinyl 
stearate and oleate. 
* * * * * *  
This work has been published in part in Refs. 161 and 162. 
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